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General abstract 
Effective vaccine stock management is one of the criteria for a functional vaccine supply 
chain. It ensures that the quality of vaccines is maintained and that vaccines are 
continuously available at service delivery points. The continuous availability of vaccines is a 
vital component of the health system which is required to achieve public health goals such 
as improved immunisation coverage, and universal health coverage.  
Reports on vaccine availability and stock management of vaccines in OR Tambo district of 
the Eastern Cape Province are scarce. Also, since the implementation of the mobile device 
for stock reporting, stock visibility solution (SVS), no study has explored the experiences of 
the health care workers in order to identify potential barriers and facilitators to the 
implementation of the system. This study was therefore aimed at assessing the vaccine 
stock management status as well as availability of vaccines in the OR Tambo district, in 
Eastern Cape Province, South Africa.  
As part of the literature review, we firstly gathered evidence on occurrence of vaccine stock -
outs at different levels of the supply chain; the national, district, health facility level in the 
WHO African region. A systematic search of the literature was conducted to identify studies 
reporting on vaccine stock-outs at these levels. Furthermore, a cross-sectional study was 
conducted to assess the occurrence of vaccine stock-outs and vaccine stock management 
practices in primary health care settings in the Eastern Cape province, South Africa. Data 
was collected from a total of 64 PHC facilities using a researcher administered 
questionnaire, record checks and direct observation. This was followed by a qualitative study 
to explore the perceptions and experiences of the SVS system amongst healthcare workers 
(HCWs) who are involved with managing stock levels of medicines in primary health care 
facilities in the Eastern Cape Province. Consequently, a scoping review was conducted to 
summarise currently available information on interventions for vaccine stock management.  
Quantitative data was managed using an electronic data capturing tool, REDCap, and 
descriptive statistics, and Pearson’s chi-squared test, were conducted using STATA® 
Version 14. The qualitative data was analysed using thematic analysis.  
Based on the JRF data, approximately 50% of the countries in Africa reported stock-outs of 
at least one vaccine for at least one month at national and district levels, in 2017. Fourteen 
(30%) countries reported vaccine stock-outs in 2017 at the national level. BCG vaccine is the 
most affected vaccine, with an increase from five countries in 2010 to 16 counties in 2015. 
There is an 86% chance of stock-out at the district level is caused by stock-out at the 
national level being linked to national level stock-outs and a 62% chance of this leading to 
interruption of immunisation services at the facility level.  At the facility level stock-outs 
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reports from Africa were few. We found a total of eight studies that reported vaccine stock-
outs across Africa; South Africa (5); Nigeria (1); Guinea (1) and Kenya (1) and Ethiopia (1). 
Poor stock management, disease outbreaks, poor supply chain structure, delays in 
deliveries and lack of trained health personnel are possible causes of facility level stock-
outs.  
Both stock cards and the stock visibility solution (SVS) device were used in all the facilities 
for vaccine stock management. However, the health care workers were reluctant to fill in the 
stock cards. Less than half of the facilities visited 27 (44%) filled their stock cards regularly. 
The ordering system was weak; as only about half 31(49%) of the respondents understood 
the concept of maximum and minimum stock levels, which are needed for proper 
quantification of needs. Delays in receiving supplies from the pharmaceutical depot were 
commonly reported by facilities, which could have contributed to stock-outs. Common 
reasons for delays from the depot include staff shortages at the pharmaceutical depot 
causing a backlog of orders, delay from the suppliers, procurement delays and possibly lack 
of proper communication between the depot and the facilities.  
A total of 49 (77%) health facilities had at least one stockout for at least one vaccine on the 
day of the visit. Furthermore, BCG and OPV were the most commonly affected vaccines in 
37 (58%) and 28 (44%) facilities, respectively. Within the last two years (between February 
2017- February 2019), BCG and OPV had the most prolonged median duration of 167 and 
103 days, respectively. PCV experienced the most prolonged duration of stock-outs amongst 
the newer vaccines with a median duration of stock-outs of 85 days. 
Four studies met our inclusion criteria (three before-after studies and one randomised trial). 
Three studies were conducted in low- and middle-income countries, while one was 
conducted in Canada. All the studies had various limitations and were classified as having a 
high risk of bias. Study findings suggest that use of digital information systems to improve 
information and stock visibility, coupled with other interventions (such as training of health 
care workers on the use of innovative tools and redesign of the supply chain to tackle 
specific bottlenecks) have the potential to increase vaccine availability, reduce response 
times, and improve the quality of vaccine records. Although more of well-designed studies 
are needed to strengthen the evidence base.  
The SVS system was well understood by most HCWs, as a system for reporting stock levels 
to managers. They also displayed high commitment to ensuring the systems works. 
However, some factors were identified as potential barriers for efficient usage of the system. 
This includes staff shortages and high staff turnover, lack of responses from the managers, 
the extra workload that comes with the system, amongst others. The HCWs made various 
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suggestions for how the system might be improved, most pertinently the need for more 
pharmacists and pharmacy assistants and for these cadres to be primarily in-charge of stock 
management and the use of the SVS. 
The OR Tambo district of South Africa, just like in other countries, suffers from vaccine 
stock-outs especially BCG, and OPV. Similarly, the lack of proper stock management linked 
to the use of manual stock cards, long response time from the pharmaceutical depot and 
inadequate fridge capacity may be responsible for stock-outs in the primary health care 
facilities in OR Tambo district. Interventions for improving vaccine availability should be 
considered, especially those focused on the factors highlighted above.  
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CHAPTER ONE 
1.0. Background  
1.1. Expanded Programme on Immunisation in South Africa 
The Expanded Programme on Immunisation (EPI) has contributed immensely to the 
reduction of deaths in children due to infectious diseases and has made a substantial 
contribution to human development1–3. The EPI in South Africa (EPI-SA) became an entity in 
1995 with the birth of democracy. Before this, there were only six antigens covered by 
vaccines in the national schedule then: diphtheria, tetanus, pertussis (DTP), measles, polio, 
and tuberculosis. Since then, significant milestones have been achieved. Examples include 
the elimination of polio, in which the last wild poliovirus case was in 1989;  elimination of 
neonatal tetanus in 2002; and the introduction of new vaccines such as rotavirus vaccine 
and pneumococcal conjugate vaccine (PCV) in 2009 and human papillomavirus (HPV) 
vaccine in 2014.4 The introduction of PCV in South Africa led to a dramatic decline of deaths 
caused by pneumococcal diseases in both children and adults5. In 2015, South Africa 
became the first country in Africa to replace the pentavalent vaccine, diphtheria, tetanus, 
acellular pertussis, inactivated polio vaccine and Haemophilus influenzae type B, (DTaP-
IPV-Hib) with hexavalent vaccine; diphtheria, tetanus, acellular pertussis, inactivated polio 
vaccine and Haemophilus influenzae type B, hepatitis B vaccine (DTaP-IPV-Hib-HBV)6,7. 
The EPI-SA schedule as revised in December 2015 is shown in Table 1. Despite these 
achievements, the EPI-SA is faced with some challenges such as reported outbreaks of 
vaccine-preventable diseases, including measles and diphtheria outbreaks, in several parts 
of South Africa7, vaccine stock-outs and as well as concerns around immunisation 
coverage1,6,8,9. 
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Table 1: The current EPI schedule in South Africa 
Age group Vaccine 
Mode/site of 
administration  
Birth 
Bacille Calmette Guerin (BCG) Intradermal/Right arm 
Oral Polio Vaccine (OPV) (first dose) Drops by mouth  
6 weeks 
OPV (first dose) Drops by mouth 
Rotavirus Vaccine RV (first dose) Liquid by mouth 
Diphtheria, Tetanus, acellular Pertussis, 
Inactivated Polio Vaccine, Haemophilus 
influenzae type b, and Hepatitis B, 
combined as (DTaP-IPV-Hib-HBV) (first 
dose) Intramuscular /Left thigh 
Pneumococcal Conjugate Vaccine (PCV) 
(first dose) Intramuscular/Right thigh 
10 weeks DTaP-IPV-Hib-HBV (second dose) Intramuscular /Left thigh 
14 weeks 
DTaP-IPV-Hib-HBV (third dose) Intramuscular /Left thigh 
PCV (second dose) Intramuscular/Right thigh 
RV (second dose) Liquid by mouth 
6 months Measles (first dose) Subcutaneous/Left thigh 
9 months PCV (third dose) Intramuscular/Right thigh 
12 months Measles (1) Subcutaneous/Right arm 
18 months DTaP-IPV-Hib-HBV (fourth dose) Intramuscular/Left arm 
6 years (Boys and 
Girls) 
Td vaccine (Tetanus and reduced strength 
of diphtheria) Intramuscular/Left arm 
12 years (Boys 
and Girls) Td vaccine Intramuscular/Left arm 
 
Source: https://www.westerncape.gov.za/service/immunisation (accessed on 25 August 
2019). 
 
1.2. Vaccine supply shain 
A functional vaccine supply chain is a critical element of an immunisation programme.10,11 
The current demands on the vaccine supply chain and other components of the EPI are 
much higher than the demands of the 1970s when the EPI programme was first designed. 
These include the increase in the number of available vaccines, storage requirements (due 
to the presentation of vaccines as single vials, as opposed to much earlier when multi dose 
vials used in the earlier days) that have significantly ballooned, and increased cost of 
vaccines. In fact, the number of doses of vaccines per individual has increased by six folds 
since 1974. It is projected that between 2011 and 2020 alone, the volume of vaccines will 
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increase by four folds; which will further increase the burden on immunisation services and 
more specifically on the vaccine supply chains11,12. Generally in this decade (2011-2020) 
many more countries have introduced newer and underutilised vaccines, coupled with other 
innovations.These developments  further increase the burden of the already strained vaccine 
supply chain,13,14 and resource-constrained countries are faced with the challenge of 
efficiently managing the current supply chain systems.15   
The availability of vaccines in their right quantities is necessary to achieve targeted health 
goals.16 Understanding the challenges and constraints of supply chain systems is essential 
for developing interventions to improve the performance of this system.16 One of the most 
critical areas in the vaccine supply chain is ensuring consistent and continuous availability of 
quality vaccines.17 When health facilities lack sufficient quantities of quality vaccines required 
for scheduled immunisation services, these sessions are cancelled leading to missed 
opportunities for vaccination, which will eventually reduce immunisation coverage17. 
Health product supply chains, in general form the backbone of a health system. The 
availability of potent vaccines in the right quantities is necessary to achieve targeted health 
goals16. The requirements of an effective supply chain is much more than the: vehicles, 
containers, storage facilities. It involves a combination of the people, organisation, and other 
resources such as information  systems all put together to ensure that health products move 
from their point of manufacture to the end user and the recipients at health facilities.16 Weak 
vaccine supply chains reduce the public health impact of immunisation services as a result 
of a decrease in  immunisation coverage caused by vaccine stock-outs; delay the 
introduction of new vaccines, increase vaccine wastage due to likely accidental exposure to 
extreme temperatures.18 
Supply chain management involves overseeing the steps involved in moving a product from 
supplier to end-user.19 Usually, when vaccines arrive in a country, they are stored in the 
central store, which is the national level store. Depending on some factors like the size of a 
country, or the number of health facilities, they are distributed to the regional or district level 
stores. From the regional stores, they are distributed to the health facilities. However, in 
some countries like Kenya, products could move directly from national stores to facilities.16,17 
While in the health facilities, they are stored until administered to recipients  or sent further to 
secondary health facilities16,17. Distribution from the national level to lower levels vary from 
country to country. For some countries such as South Africa, Zambia and Tanzania, 
distribution from national level to lower level is every month while in others such as the 
Gambia, Kenya and Mozambique, it is every three months.16,20 The lower levels could either 
be the health facilities or sites for outreaches.16,17 The health facilities receive their vaccine 
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supplies through two types of systems, the push and pull system. The push system involves 
the higher level store such as the national store, district-level store or regional store deciding 
the number of products to be delivered to a health facility. This decision is made based on 
the target population, the incidence of disease and other factors. The push system may be 
used when the lower level in the supply chain cannot or is not able to or adequately manage 
its vaccine stock and place orders. On the other hand, the pull system operates from the 
level of the health facility, where by requisitions are made by the health facility based on their 
consumption, stock level and other factors16.  
1.3. Overview of the vaccine supply chain in South Africa  
There are four levels of the vaccine supply chain in South Africa: national depot, provincial 
depot, district and sub-district depots, and service delivery points (as illustrated in Figure 1 
below). Supply chain functions at the national level are outsourced to the Biovac Institute, 
that is in a public-private partnership with the South African national department of health 
(NDOH). According to the agreement, the Biovac institute manages three aspects of the 
vaccine supply chain: procurement of vaccines for the country, central level storage and 
distribution of vaccines from central level to the nine provincial storage depots.21 The 
national department of health has the role of  forecasting annual national vaccine 
requirements. When vaccines arrive the national depot, they are transported to provincial 
depots, from provincial depots they are transported to the district and or sub-district depots, 
and from these to health facilities where children and pregnant women (where appropriate) 
are vaccinated 21,22. 
This model of the vaccine supply chain in South Africa is outlined in the flow diagram below: 
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Fig 1: Schematic diagram showing the distribution of vaccines in South Africa 
 
 
1.4. Vaccine stock management 
The supply chain cycle for every health product is comprised of several components, 
namely: product selection, quantification, procurement, inventory/stock management, 
distribution, and ensuring rational use.23 Each stage is important and is related to other 
stages, such that the problems encountered in any of these elements may have an impact 
on the entire supply chain system.23 The success of immunisation programmes depends 
mostly on a well-functioning supply chain,24,25 which ensures that vaccines are continuously 
available from the manufacturers through the different levels of the supply chain up to the 
target population.26 Effective vaccine stock management is one of the criteria for a functional 
vaccine supply chain.27 Effective vaccine stock management helps to: maintain the quality of 
vaccines27,28,  prevent vaccine stock-outs and ensure continuous availability of vaccines to 
the target population. Vaccine stock management at health facility level involves activities 
that should be performed daily;  including checking and monitoring of vaccines upon arrival 
at a storage point, during storage, and when they are administered to the recipients.27,28 
Physical stock counts should also be carried out regularly to validate stock records. 27,28  
Stellenbosch University https://scholar.sun.ac.za
6 
 
The purpose of the vaccine stock management system in a supply chain is to ensure that 
vaccines are moved from the source to those who need them at the right time and in a cost 
efficient manner27. At the health facility level, this implies that vaccine stocks are expected to 
be kept in the right quantities at all times27.  In order to ensure that the quality of vaccines is 
maintained, there is a need for accurate stock records. These vaccine stock records capture 
all the information on the vaccines, their diluents, and consumables such as syringes. This 
information includes arrival date; quantities of vaccines received, dispensed, and stock 
balances (quantities remaining); batch numbers; vaccine expiry dates; and the status of 
temperature monitoring indicators. 20,279,26 Ensuring consistent availability of sufficient 
quantities of vaccines depends on adequate the stock management processes that are 
consistently  applied.20,27  Stock management involves tracking the consumption rate of a 
product, and this helps the storekeeper to measure the future needs of the facility. Stock 
cards and stock books are common tools used to keep stock records29. These tools can be 
used to determine the average consumption rate for a defined period, minimum and 
maximum stock levels as well as timing the order of a particular product.29  Vaccines are 
expected to be kept within the minimum and maximum stock levels. The minimum stock 
level is the least amount of vaccines that a facility should always have. It is expected that 
stocks should not drop below this level. To avoid stock-outs, it is expected that facilities 
maintain accurate minimum stock levels. It is also expected that physical counts of vaccine 
stocks be carried out regularly to verify stock records. Furthermore, facilities are expected to 
have a ‘safety stock’ which is that reserve stock that is used to prevent stock-outs that may 
arise due to unforeseen circumstances like delivery delays, shortages at supplier level, etc. 
This safety stock forms part of the minimum stock that a facility is expected to maintain. 
These stock levels usually depend on the consumption level of a facility 20,27.  
According to WHO, an ideal vaccine stock management system should:  
• “Ensure that vaccines received are of assured quality by meeting the norms specified 
by the national regulatory authority or WHO; 
• Ensure the availability of adequate quantities of relevant immunisation-related 
supplies (diluent, syringes and needles) to guarantee safe administration; 
• Avoid stock-outs to ensure uninterrupted implementation of immunisation activities; 
• Maintain proper handling and storage conditions to avoid overstocking and 
unnecessary expiration of materials before utilisation; Ensure adequate cold store 
capacity for vaccines at recommended storage temperatures and adequate dry store 
capacity for injection supplies”30.  
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1.5. Indicators commonly measured during the assessment of the stock 
management procedures 
Vaccine stock-out rates: measures product absence over a period (12 months in this 
study). It is expressed as: (number of facilities that experienced a stockout of a specific 
vaccine/total number of facilities that are expected to provide that vaccine X 100. Data will 
be obtained from physical inventories, Logistics management and information systems 
(LMIS) records, stock cards/computer files or supervision records, where available. 
Inventory accuracy rates: This indicator measures the accuracy of data on product stock 
levels at a facility and provides information on how accurately the facilities are tracking their 
inventories. It measures whether stock balances recorded on a stock ledger, stock cards or 
automated systems are similar to the actual inventory on hand. This indicator is important 
because the actual stock-on-hand is essential for forecasting and procurement purposes.  
Formula: (number of items where stock record count equals physical stock count / total 
number of items counted) X 100      
Stocked according to plan: This measures the percentage of facilities with stock levels 
above the established maximum level for each vaccine at a specific point in time. It helps 
reveal overstocking or low stock levels. Formula: (number of facilities with stock levels 
between the established maximum or minimum levels/total number of facilities visited) X 
100. 
Response time: Also referred to as order lead time, the response time measures the 
average time it takes from when an order is placed from the facility to a higher facility (e.g. 
the district store) to when its order is received during a specified period (12months).  
Formula for measurement of lead time: the sum of the number of days between when orders 
were placed and when orders were received/ total number of orders placed. 
1.6. Approaches for addressing vaccine stock management issues.  
Due to the upward trend in the rates of vaccine stock-outs, countries are currently using 
various approaches to manage vaccine stocks.31,32 Such approaches include most 
commonly the use of digital technology in stock management. Using digital tools such as 
mobile devices in health care has the potential to strengthen health systems, in low and 
middle-income countries and improve global health33.  This is possible due to the growing 
use information technologies in public health, a concept known as e health. The World 
Health Organisation (WHO) defines eHealth as “the use of information and communication 
technologies (ICTs) for health to, for example, treat patients, pursue research, educate 
students, track diseases and monitor public health”3334. Mobile health is a component of e-
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health, where mobile devices are used to assist public health activities and ultimately to 
improve health outcomes35. The Global Observatory for eHealth defined mHealth as 
“medical and public health practice supported by mobile devices, such as mobile phones, 
patient monitoring devices, personal digital assistants (PDAs), and other wireless devices”36. 
Mobile health has increasingly being adopted for several purpose in low and middle-ncome 
countries with great potentials37. It is currently being applied in various programmes such as 
maternal and child health, and programmes reducing the burden of the diseases, including 
HIV/AIDS, malaria, and tuberculosis 36 to improve timely access to health services and 
information, managing patient care, reducing drug shortages, improving clinical diagnosis 
and treatment adherence, among others3638.A systematic review conducted by Oliver-
Williams and colleagues showed that mhealth has the potential to increase vaccination 
uptake. In their study they described studies where mobile devices were used as reminders 
for health care givers and  as a  means of interactions between health care workers.39 
Mhealth also has the potential to improve the availability and quality of data in the health 
supply chain40. This is because data is needed to inform health managers on how the supply 
chain is functioning, understand where challenges are and make informed decisions. Lack of 
adequate data affects vaccine availability; because orders are not informed by consumption 
figures. Subsequently, ill-informed orders could lead to shortages and even wastage. 
Vaccine stock management systems are typically still manual and mostly paper-based. 
Stock transactions are captured on paper, including vaccine stock (bin) cards and reports 
are sent to supervisors who make informed decisions based on the reports.41 This, leads to 
inadequate information that is not able to support decision making due to various factors 
such as poor estimates, data arriving too late, poor data quality. Some countries use 
dashboards to visualize vaccine stock status. These dashboards measure performance and 
make them visible for managers to make informed decisions. Countries like India, 
Mozambique, and Nigeria use these dashboards to improve vaccine availability.42,43   
South Africa developed the stock visibility solution (SVS), an mhealth system, to reduce the 
rate of stock-outs and improve the availability of essential drugs, which include vaccines. 
The SVS allows vaccine managers at higher levels in the supply chain to be better informed 
of the quantity of essential drugs at hand in health facilities. This should be helpful during 
distribution to avoid overstocking (which leads to vaccine wastages) or understocking (which 
leads to vaccine stock-outs).31  The SVS involves the use of a mobile application designed to 
enable health facilities to monitor and capture stock levels daily. The information is stored in 
a cloud-based data management system and can send alerts when the stock is running low 
(Fig 2).44It enables health workers to replenish stock proactively.44 The SVS is currently 
being used in 3126 clinics in eight out of the nine provinces in South Africa, except the 
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Western Cape Province.45 The SVS was piloted in KwaZulu-Natal and Limpopo provinces in 
2014 and 2015 respectively. There was a reduction in the number of stock-outs by 14% and 
42% in Kwazulu-Natal and Limpopo respectively.45 However, the method for measuring 
these variables was not mentioned. The use of the SVS approach looks promising. 
However, there has not been a significant reduction in the rate of stock-outs in many 
facilities in South Africa as of 2015, as there were still reports of stock outs.44 The Stop Stock 
Outs Project (SSP) by a civil society organisation that conducts annual telephonic surveys to 
check on shortage of pharmaceuticals right through the country, still reports vaccine stock-
outs44,46. However, the method used by SSP might require validation as there are 
reservations as to the validity of the method used for reporting 45,47.  Malawi has similar kind 
of mobile technology for capturing and monitoring vaccine stock level.48  
 
 
 
Figure 2: An illustration showing how the SVS works (Source: Mandimika 201649) 
1.7. Vaccine shortages and stock-outs  
The incidence and duration of vaccine stock-outs are the most common indicators for 
measuring vaccine availability.50 It is ideal for measuring stock-out rates at the lowest level of 
Stellenbosch University https://scholar.sun.ac.za
10 
 
the supply chain.50 Following the resolution of the World Health Assembly to address global 
shortages of medicine and vaccines, a group of experts came up with definitions of stock-
outs and shortages which are still subject to change. According to these experts, shortage 
occurs when “the supply of medicines, health products, and vaccines identified as essential 
by the health system is considered to be insufficient to meet public health and patient 
needs”, and stock-outs are defined as “the complete absence of the medicine, health 
product, or vaccine at the point of service delivery to the patient”.51,52 Various studies that 
have assessed the supply of vaccines and other health commodities have used this 
definition. 53–55 
Many countries across all income groups have reported vaccine stock-outs 51. For example, 
global data analysis of effective vaccine management (EVM) assessments between 2009 
and 2014 showed that most countries performed below the minimum standard for stock 
management 56. Vaccine stock-outs at primary healthcare facilities is one of the challenges 
facing the EPI in South Africa, and it is an undeniable threat to the success of the 
immunisation programme and the health of the people of South Africa.44,57  Vaccine stock-
outs tend to occur more at the primary health care facilities than at the supply levels above, 
i.e. the district and provincial depots.58 In keeping with observations made elsewhere, 
vaccine shortages in South Africa seem to have increased since the introduction PCV, and 
rotavirus vaccine (RV), and the pentavalent vaccine.6 The latter contains diphtheria, acellular 
pertussis, tetanus, Haemophilus influenzae type b, and inactivated poliovirus antigens. A 
national evaluation conducted in all provinces by the National Department of Health, the 
World Health Organisation (WHO), and the United Nations Children Fund (UNICEF) in South 
Africa after the pentavalent vaccine, PCV and RV  were introduced, found that more than 
60% of facilities visited experienced vaccine stock-outs in the 18 months period from 
December 2009 to July 2011.6 Surveys conducted within the context of the “Stop Stock Out” 
project have reported similar findings. The “Stop Stock Out” surveys are mainly based on 
telephone interviews to identify facilities where stock-outs occur.44 Vaccine stock-outs and 
child deaths due to vaccine-preventable diseases are common in rural communities which 
are remote and most have poor infrastructure and  are hard to reach.59 
Weak supply chains lead to weakness of the entire health system, putting the lives of 
patients in danger. Understanding the magnitude of a problem is one of the steps taken 
towards solving the problem. Also, identifying root causes of stock-outs is important for 
developing interventions that could solve these issues.16 During the 69th World Health 
Assembly (WHO) in 2016, member states were advised to develop strategies that may be 
used to either forecast, avert or reduce the stock-outs of vaccines and other essential 
medicines. Such strategies should align with the priorities of each country such as the use of 
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notifications for predicting shortages, ensuring that standard procedures for procurement, 
distribution and contact management are adhered to; to develop and or strengthen systems 
that can be used to monitor supply, demand and availability of vaccines and other 
medicines, and be able to notify procurement departments when there are issues with 
availability amongst others.24  
Chapter two of this dissertation will examine the magnitude of stock-outs at all levels of the 
supply chain in Africa, using a systematic review. Apart from highlighting the magnitude of 
vaccine stock-outs, this systematic review will assess the causative factors of vaccine stock-
outs at the health facility level.  
1.8. Study rationale 
While South Africa has made significant progress with the introduction and self-financing of 
new and underutilised vaccines1,6,9, vaccine shortages at the facility level seem to have been 
a challenge.  There have been reports that point to significant shortages of vaccines in many 
parts of the country which have been more of a serious challenge since the introduction of 
new vaccines 6,44. However, despite these reports, there is limited information on the actual 
shortages of vaccines and their impact; especially in certain parts of the country such as the 
Eastern Cape Province. Specifically, there is no literature on the level of availability and 
stock management of vaccines in OR Tambo district of the Eastern Cape Province, one of 
the most rural districts in the country. Finally, with the introduction of the SVS, it is important 
to understand the experiences of health care workers using the system, to understand their 
views regarding its effectiveness in reducing occurrence of stock-outs in primary health care 
facilities.  
As a background to this study, a review of the availability of vaccines at different levels of the 
supply chain in the WHO Afro region, was conducted. This was followed by an assessment 
of vaccine tock availability and stock management practice in OR Tambo district. 
Subsequently, a scoping review was conducted to identify interventions that are used for 
vaccine stock management in primary health care facilities. Finally, we explored the 
perceptions and experiences of health care workers, using the SVS for monitoring and 
reporting of vaccine stock levels. 
1.9. Summary of background and conceptual framework  
Access to vaccines is critical to achieving universal health coverage. It is also critical to 
achieving the strategic goals of the Global Vaccine Action Plan (GVAP), which includes 
improved immunisation coverage.11 The supply chain involves a combination of the people, 
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organisation, resources, information; all working together to ensure that health products 
move from their point of manufacture up to the patients who receive them.16 The vaccine 
stock management is a critical component of the vaccine supply chain, and poor stock 
management has been linked to the occurrence of vaccine stock-outs. At the health facilities, 
the major causative factor for stock-outs is poor stock management, especially when 
vaccines are available at the higher level of the supply chain. 60,61  
The conceptual framework used in this study was drawn from the WHO effective vaccine 
management (EVM) assessment and other areas the literature regarding the vaccine supply 
chain. The EVM is an initiative launched by WHO and UNICEF to help low- and middle-
income countries upgrade their immunisation supply chains in order to manage present and 
future procedures. This initiative began by establishing a process to help developing 
countries evaluate the current performance of their supply chain and comparing it with the 
set standards. An EVM assessment tool was therefore created to achieve this purpose, to 
assess immunisation supply chain at all the relevant levels of the system, from the national 
to the service delivery levels. There are nine areas that are assessed by this tool: vaccine 
arrival, temperature control, storage capacity infrastructure, maintenance, stock 
management, distribution, vaccine management and information systems. At the health 
facility level, the vaccine arrival and information systems are not assessed. Eventually, EVM 
is expected to help countries ensure that lifesaving vaccines are available, are in good 
quality when they reach service delivery levels and improve efficiency of every country’s 
vaccine supply chain.62 The conceptual framework below illustrates the interplay between 
factors that cause vaccine stock-outs at the health facilities, with a focus on vaccine stock 
management.  
 Figure 2 below describes the conceptual framework developed for this study to aid in data 
collection 
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Figure 3: The conceptual framework showing factors that influence vaccine stock 
management and stock-outs 
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1.10. Aim of the study 
This study aims to evaluate vaccine stock management status of primary healthcare facilities 
and the availability of vaccines in the Eastern Cape Province of South Africa.  
1.11. Specific objectives of the study 
i. To conduct a systematic review of both published and grey literature on occurrence 
vaccine stock-outs in WHO African region in the decade of vaccines. 
ii. To assess the standard of vaccine stock management in selected primary healthcare 
facilities in the Eastern Cape Province of South Africa. 
iii. To establish the level and frequency of vaccine stock-outs in selected primary 
healthcare facilities in the Eastern Cape Province of South Africa. 
iv. To conduct a scoping review of the approaches for vaccine stock management, to 
reduce stock-outs in primary healthcare settings.  
v. To explore the perceptions and experiences of health care workers using the stock 
visibility solution (SVS), in the Eastern Cape Province of South Africa.  
 
1.12. Structure of the dissertation 
This dissertation is structured into six chapters, mainly written in manuscript format.  Chapter 
1 provides a background to the study. Here we discuss the benefits of immunisation through 
the EPI, including the achievements and successes of the EPI in South Africa. This chapter 
also describes the vaccine supply chain and how important it is in achieving health goals, 
particularly immunisation goals. Furthermore, the concept of vaccine stock management is 
discussed and how it impacts on vaccine availability. This is then followed by a description of 
vaccine stock-outs and its impact on the health system.  
Chapter 2: To build upon the concepts of vaccine stock-outs, Chapter 2 describes the 
occurrence of vaccine stock-outs in the WHO African region, including the national level, 
district and health facility level. It also describes the link between national level stock-out and 
district stock-out and the impact on immunisation services. The causes of vaccine stock-outs 
at the health facility level is also highlighted in this chapter. A systematic review of both 
published and grey literature on the occurrence of stock-outs was conducted. Also, the 
WHO/UNICEF joint reporting form is used as a data source for national and district level 
vaccine stock-outs. 
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Chapter 3: This chapter shows the findings of the primary study conducted in the Eastern 
Cape province of South Africa. That is, findings from the assessment of vaccine stock-outs 
and stock management in primary health care facilities, in OR Tambo District, Eastern Cape.  
Chapter 4: From findings from Chapter 3, we found that stock-management issues are the 
most frequent causes of vaccine stock-outs at service delivery points. So, we decided to 
conduct another scoping review of the literature to identify interventions that can be used to 
improve vaccine stock management and vaccine availability. This study has been published 
in Human vaccines and immunotherapeutics 
(https://www.ncbi.nlm.nih.gov/pubmed/31116638) 
 
Chapter 5: Chapter dealt with a qualitative study on the perceptions and experiences of 
health care workers on the use of SVS.  
Chapter 6: This chapter is a general discussion and conclusion. It also describes a summary 
of key findings, benefits of the study, contribution to knowledge, study limitations and future 
research considerations.  
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2.0. Abstract 
Introduction  
Despite the many benefits of immunisation, the WHO African region is still faced with 
challenges, in terms of vaccine availability. In this study, we describe the occurrence of 
vaccine stock-outs at the different levels of the supply chain; national, district and health 
facility level in the WHO African region. We conducted a systematic review to search to 
identify studies reporting on vaccine stock-outs at these levels.  
Methods: 
We searched both published and grey literature to identify studies that reported on vaccine 
shortages and stock-outs at national, district levels and health facilities, in the decade of 
vaccine (between 2010 and 2017). The following databases were searched; PubMed, 
Embase, Cochrane Central Register of Controlled Trials (CENTRAL). Also, we searched the 
following websites for grey literature; WHO/UNICEF Joint Reporting Form (JRF), TechNet21, 
UNICEF, GAVI, PATH, and the reference sections of eligible studies. 
Data for national and district stock-outs were extracted from 2018 WHO/UNICEF JRF, that 
reports on 2017 data. We focused on BCG, DTP, Measles and OPV. Data were captured in 
Microsoft excel and analysed using descriptive statistics.  
Results:  
Based on the JRF data, approximately half of the countries in Africa reported stock-outs of at 
least one vaccine for at least one month at national and district levels, in 2017. Fourteen 
(30%) countries reported vaccine stock-outs in 2017 at the national level. BCG vaccine is the 
most affected vaccine, with an increase from five countries in 2010 to 16 counties in 2015. 
There is an 86% likelihood of stock-out at the district level is caused by stock-out at the 
national level being linked to national level stock-outs and a 62% likelihood of this leading to 
interruption of immunisation services at the facility level.  At the facility level, stock-outs are 
underreported but still occur. We found a total of eight studies that reported vaccine stock-
outs across Africa; South Africa (5); Nigeria (1); Guinea (1) and Kenya and Ethiopia (1). Poor 
stock management, disease outbreaks, poor supply chain structure, delays in deliveries and 
lack of trained health personnel are possible causes of facility-level stock-outs.  
Conclusion: Countries within the WHO African region still report stockouts at all the levels 
in the supply chain and this impacts on the delivery of immunisation services. The frequency 
and the proportion of subnational levels that experience stock-outs vary between countries 
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and between regions within a country. Countries need to put more efforts towards finding 
lasting solutions to vaccine shortages.  
Keywords: Vaccine stock-outs, shortages, immunisation, Supply chain, availability, Africa 
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2.1. Introduction 
Gains of the Expanded Programme on Immunisation (EPI) in Africa have been significant.  
The EPI program has led to a reduction in the burden of vaccine-preventable diseases, with 
diseases such as polio and neonatal tetanus being close to elimination. 1–3 There is equally 
evidence from return on investment (ROI) studies in low-and middle-income countries 
demonstrating that about the cost of the illness averted, immunisation provides a net return 
16 times more than what it costs to vaccinate. Expanded estimates in this study, which 
incorporated the value people place on living longer found that the return on investment can 
be up to 44 times the initial cost 4. In order to optimise the benefit of vaccines, there has 
been accelerated progression in the introduction of new and underutilised vaccines such as 
Hepatitis B, rotavirus and pneumococcal conjugate vaccines. In thirty-six (36) out of the 47 
countries in the region, this has been supported by the GAVI alliance 5.  
The Global Vaccine Action Plan (GVAP) is a framework that was adopted by the World 
Health Assembly in 2012 to achieve the vision of the decade of vaccines (2011 – 2020) by 
delivering universal access to immunisation. The goal of this plan is that by 2020, countries 
would have achieved 90% national immunisation coverage.6,7 The vision of the decade of 
vaccine is to ensure everyone eligible for vaccination gets equal access to vaccines 
regardless of their location or income status (“where they are born, where they live and who 
they are”).6,7 One of the strategic objectives of the GVAP and the African region is to have 
strong immunisation supply systems that will ensure that vaccines are always available in 
adequate quantities and improve immunisation coverage, respectively.8,9 
As countries endeavour to increase their immunisation coverage and get closer to achieving 
universal access to life-saving vaccines as outlined in the GVAP, challenges abound. In 
2017, about 20 million children were not vaccinated.  Sixty per cent of these children come 
from 10 countries; with half of these countries in Africa, including Nigeria, Ethiopia, 
Democratic Republic of Congo, Angola and South Africa 10. Immunisation coverage in low- 
and middle-income countries (LMICs) is low, stagnant, and even decreasing for some 
countries. In the African region, immunisation coverage with the third dose of diphtheria-
tetanus-pertussis (DPT3) in the period 2010 and 2017, remained stagnant at 72%, while 
there was a 14% increase in birth cohort in the same period.2  
Supply chains are fundamental to a functional immunisation programme and ensuring that 
vaccines are always available at the point of care. Efficient supply chains will ensure an 
uninterrupted supply of vaccines at all levels, and this is an essential factor in achieving and 
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sustaining high immunisation coverage levels.11,12 Vaccine shortages result in targeted 
recipients being turned away, which lead to a decrease in immunisation coverage and 
ultimately outbreaks of vaccine-preventable diseases.13 Additionally, it is evident that 
repeated shortages will lead to a decrease in demand for immunisation services, dent the 
image of the programme and further undermine national and global efforts on disease 
control.12  
Furthermore, a study by Lydon et al.14 examined global levels of vaccine shortages found 
that one in three countries are out of stock of at least one vaccine every year and the 
shortages were much more common in Sub- Saharan Africa, with 38% of countries reporting 
national level stock-out. Of further concern from this study is that, when national stock-outs 
occur, there is 89% likelihood of district level stock-out, resulting in 96% chance of 
interruption of services at facility level (Figure 3). The global shortage of BCG has been well 
documented and has led to estimates of its potential impact. The Western Cape province in 
South Africa, for example, has recorded a sharp increase in the incidence of tuberculous 
meningitis and is this has been attributed to BCG vaccine shortages.15 
Causes of vaccine shortages are many, and shortages may occur at any level in the supply 
chain. Of serious concern is shortages that occur at the district level and even more 
frequently at the facility level. Vaccine shortages and stock-outs that occur at district and 
facility levels when there is no national shortage, are mainly due to poor stock management 
and these are quite significant 16. They are likely to go on for long periods unreported, 
undetected and may have a greater impact on immunisation coverage.  
It is against this backdrop that we assess the magnitude of vaccine stock-outs at all levels, in 
the WHO African region since the beginning of the decade of vaccines. This study aims to 
determine the occurrence of vaccine stock-outs, the duration of stock-outs at both national, 
district and facility levels as well as the impact on immunisation services.  
 
2.2. Methods 
2.2.1. Identification of vaccine stock-outs reported at the national and 
district levels in Africa 
Data source:  
Data based on the WHO Joint Reporting Form (JRF) was used. WHO and the United 
Nation’s Children’s Fund (UNICEF) collect data annually on the performance of the 
immunisation programmes from all WHO member states using the JRF. This data collection 
has been ongoing since 1998 and is available to the public. We retrieved the data from the 
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vaccine supply category of the JRF on the 3rd of December 2018, after it had been updated 
on the 28th of October 2018 [16]. This category has five main questions, namely: 
• “Is there a stock-out at the national level” for BCG, (and other vaccines)? 
• “If yes, specify the duration in months.”  
• “Is there a stock-out in any district for BCG, (and other vaccines)? 
• “Was the district level stockout linked to a national one for any of the vaccines? 
• “Vaccination services interrupted because of lack of the vaccines?” 
Each question in this category for JRF is answered by countries with a yes (Y); no (N); not 
applicable (NA) or not reported (NR). Data was captured for only the “yes” responses for 
each vaccine and each year from 2010 to 2017. For quality checks, results were adjusted for 
any country that reported the duration of stock-outs but failed to report “Yes” to the question 
on stock-outs. If such countries failed to report yes for the national level stock out, we had to 
adjust the result to become “Yes” for that country since there is a high likelihood that there 
was a mistake in reporting. 
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Figure 3: The link between the occurrence of national-level stock-outs and district 
level stock-outs and their implication of delivery of immunisation services, at a global 
level 14 
 
Inclusion criteria and considerations for analysis of vaccine stock-outs from the 
WHO/UNICEF Joint Reporting Form: 
The study was limited to countries in the WHO African region. We included only vaccines 
that are common in the immunisation schedules of children between 0 – 12 months of age, 
for all countries in the WHO African region. We focused on stock-outs of vaccines for the 
period from 2010 to 2017, with 2011 serving as the baseline. We included: BCG, diphtheria-
tetanus-pertussis (DTP) containing vaccines, measles, oral polio vaccine (OPV) and 
pneumococcal conjugate vaccine (PCV). Since these vaccines are the most commonly used 
in the countries within this region. Other vaccines such as yellow fever, meningococcal type 
A conjugate vaccine (Men A), human papillomavirus (HPV), rotavirus, and tetanus toxoid 
were excluded from the analysis. 
The following indicators were measured:  
i. The number of countries reporting national level stock-outs for each vaccine between 
2010 and 2017. This was calculated from the countries that responded yes to the 
question on “was there a national level stock-out?”. 
ii.  The number of countries reporting stock-out of at least one vaccine for at least one 
month or each year, between 2010 and 2017.  
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iii. The average duration of stock-outs at the national level stock-outs for each vaccine, 
between 2010 and 2017 
iv. The number of countries reporting stock-outs at the district level  for the individual 
vaccines for each year. This was obtained by calculating the total number of countries that 
answered a “yes” to the question “Is there a stock-out at the district level for BCG, DTP, 
Measles and OPV 
v. Number of countries with stock-outs at the district level that were due to the national 
level stock-outs, for each vaccine and each of the years under study.  
vi. The number of countries with vaccination services interrupted due to stock-outs at 
the district level. 
Apart from measuring the average duration of stock-outs for each year, the duration of stock-
outs based on the number of stock-out events was also described. This expression attempts 
to provide a broader picture of the duration of stock-outs at the national level. A stock-out 
event is defined as stock-out lasting for a minimum of one month [17]. As a standard, 
countries are expected to have a safety stock that will last for three months, so stock-out of 
up to a month implies that this safety stock has been depleted and this will most likely affect 
the lower levels [13].  
Analysis: 
 Data on national and district stock-outs were captured and analysed using descriptive 
statistics. 
2.2.2. Identification of vaccine stock-outs reported at health facility 
level in Africa 
The JRF does not contain reports of facility-level stock-outs. Hence, we searched the 
literature for such studies. The following steps describe the methods used to systematically 
review the literature for facility-level stock-outs reported in the WHO African region.  
Identification of studies and search strategy:  
We considered studies that have reported vaccine stock-outs at primary health care facilities 
level in Africa, irrespective of duration, vaccine type or study design.  
Outcome measures:  
Primary outcomes:  
• Stock-out rate: “the percentage of facilities (e.g., service delivery points [SDP], 
warehouses) that experienced a stockout of a specific product that the site is 
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expected to provide, at any point, within a defined period (e.g., the past six or 12 
months)” or as defined by the authors.   
• The average duration of stock-outs 
The secondary outcome was the causes of vaccine stock-outs highlighted by the authors. 
Search strategy:   
We searched both published and grey literature for studies that reported stock-out events in 
health facilities across Africa, in the decade of vaccine (between 2010 and date). The 
following databases were searched; PubMed, Embase, Cochrane Central Register of 
Controlled Trials (CENTRAL). We also searched the following websites for grey literature; 
WHO, TechNet21, UNICEF, GAVI, Program for Appropriate Technologies in Health (PATH), 
The reference lists of eligible studies were also searched. Appendix 1 contains search 
strategy used to search for eligible studies. 
Selection of studies and data extraction:  
Two review authors independently screened through the titles and abstracts of the records 
retrieved from databases to identify potentially eligible studies. Studies reporting the 
absence of at least one vaccine in a primary health care facility were included in the study. A 
data collection form was designed and used independently by two review authors to extract 
data from the included studies. Where there was any form of disagreements, we resolved 
them through discussion and contacted a third review author in instances where the two 
authors had disagreements.  
Synthesis of data from facility level stock-outs in the WHO African region  
The occurrence of vaccine stockouts reported in each included study was not homogenous. 
Therefore, it was impossible to calculate an overall stock-out from all the studies. Hence, 
results from the included studies were synthesised narratively.  
2.3. Results 
2.3.1. Results from the WHO/UNICEF JRF on national and district 
stock-outs reports for the WHO African region 
Five vaccines were included in the analysis; BCG, DTP containing vaccine (DTP, Measles, 
oral poliovirus vaccine (OPV) and PCV. The results described below are based on these 
vaccines. Data from all the 47 countries in the WHO African region was obtained.  
National level stock-outs 
Between 2011 and 2017, there was much variation in the rates of vaccine stock-outs at the 
national level. In 2017, 49% (23/47) of all countries in the WHO African region reported a 
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stock-out of at least one vaccine for at least one month. This was lower than that of 2015, 
with 62% (29/47) of the countries reporting national-level stock-outs. The year 2015 had the 
highest number of countries reporting stock-outs at the national level.  
There was an increase in the number of countries reporting BCG stock-outs at the national 
level since 2010. In 2010, five countries (11%) reported BCG stock-outs. This increased to 
12 (26%) in 2017, with peaks of 13 countries (28%) in 2013 and 16 (34%) in 2015. There 
was a significant decrease in the number of countries that reported stock-outs of DTP 
containing vaccines, from 11 countries (23%) in 2010 to 1 in the country (2%) in 2017. 
Despite variations in the number of countries reporting stock-outs between 2012 and 2015, a 
steady reduction was observed from 2015 to 2017. Figure 4 shows a graph of the total 
number of countries reporting stock-outs between 2010 and 2017.  
 
 
Figure 4: Total number of countries reporting national level stock-outs in the WHO 
African region (2010-2017) 
There was no significant change in the number of countries reporting national level stock-
outs of measles vaccine during the study period. Four countries (9%) reported stock-outs 
both in 2010 and 2017.  There were minor variations between 2010 and 2017 in the number 
of countries reporting measles stock-outs. Oral polio vaccine (OPV) had no stock-out reports 
available from 2010 to 2013; only reports from 2014 – 2017 were available. From the 
reports, there was an increase in the number of countries reporting stock-outs of OPV from 
six countries (13%) in 2014 to seventeen countries in 2017. Table 1 below shows the 
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countries reporting national level stock-outs of BCG, DTP containing vaccines, Measles, 
OPV and PCV.  
Duration of national-level stock-outs 
The duration of stock-outs varied among countries and vaccines, ranging from one month 
(one stock-out event) to seven months (seven stock-out events). The vaccine most 
commonly affected was BCG. In 2016 and 2017, the duration of stock-outs reduced 
significantly. The duration of stock-outs for DTP containing vaccines in most countries was 
between zero to three months. Most countries in a year experienced multiple stock-out 
events of vaccines. In 2017, 15% (7/47) reported two stock-out events (lasting a month or 
more) and another 15% had three stock-out events (Table 3).  
The link between district-level stock-outs and the impact on immunisation services  
This indicator was added to the JRF in 2014, hence only results from 2014 to 2017 were 
reported (Table 2 below). In 2015, 25 countries out of the 29 that reported stock-outs at the 
national level reported that district-level stock-outs were due to national stock-outs. This 
suggests that there is an 86% chance of having a district-level stock-out being caused by 
stock-outs at the national level. In the same year, 18 countries out of 29 (62%), reported that 
there was an interruption of immunisation services.  
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Table 1: Occurrence and duration of vaccine stock-outs at the national level in WHO 
African countries between 2010-2017 
Countries reporting vaccine stock-outs of each vaccine at national level n (%) 
 
2010 2011 2012 2013 2014 2015 2016 2017 
BCG 5 (11%) 6 (13%) 7 (15%) 13 (28%) 10 
(21%) 
16 
(34%) 
9 
(19%) 
12 
(26%) 
DTP 11 (23%) 8 (17%) 4 (9%) 7 (15%) 2 (4%) 6 
(13%) 
3 (6%) 1 (2%) 
Measles 4 (9%) 7 (15%) 5 (11%) 7 (15%) 5 
(11%) 
3 (6%) 4 (9%) 4 (9%) 
OPV Not 
reported 
Not 
reported 
Not 
reported 
Not 
reported 
6 
(13%) 
4 (9%) 12 
(26%) 
17 
(36%) 
PCV 2 (4%) 1 (2%) 2 (4%) 1 (2%) 0 (0%) 1 (2%) 1 (2%) 0 (0%) 
Duration of vaccine stock-outs at the national level n (%) 
One 
month  
10 (21%) 11(23%) 12 (26%) 13 (28%) 6 
(13%) 
8 
(17%) 
9 
(19%) 
7 
(15%) 
Two 
months 
4 (9%) 2 (4%) 2 (4%) 5 (11%) 5 
(11%) 
9 
(19%) 
6 
(13%) 
6 
(13%) 
Three 
months 
4 (9%) 2 (4%) 2 (4%) 4 (9%) 2 (4%) 4 (9%) 1 (2%) 7 
(15%) 
Four 
months 
2 (4%) 2 (4%) 1 (2%) 1 (2%) 5 
(11%) 
5 
(11%) 
2(4%) 2 (4%) 
Average duration of stock outs (days) at the national level  
   
 
72 43 45 57 81 66 50 69 
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Table 2: Countries reporting district stock-outs and impact of higher-level stock-outs 
on immunisation delivery services 
 2014 2015 2016 2017 
Number of countries that reported district 
level stock-outs 
31 40 32 29 
District stock-outs caused by National 
stock-outs 
20 25 16 18 
Interruption of vaccination services 
because of lack of vaccines  
23 18 14 26 
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2.3.2. Occurrence of vaccine stock-outs at the facility level, within the 
WHO African Region 
Search results 
The literature search yielded a total of 982 records; 11 from PubMed, 966 from Scopus, and one 
from reference lists of included studies. After screening, 26 articles were retrieved for full-text 
screening, out of which eight articles were eligible for inclusion.17–24 Eighteen articles were 
excluded. Figure 5 shows the  PRISMA (Preferred reporting items for systematic reviews and 
meta-analyses) flow diagram of how studies were selected.25  
Study characteristics 
The first study was a cross-sectional study conducted by Ngcobo et al.17,  in 2013, in a rural 
district of one of the Provinces of South Africa17. The occurrence of vaccine stock-out was 
assessed in 31 primary health care facilities. Vaccine stock-outs occurred in 29% (9/31) of the 
facilities visited. The duration of vaccine stock-outs in these facilities varied between less than 
two days to over two weeks. The following reasons were reported to be causes of vaccine 
stock-outs: poor stock management, lack of trained personnel, delays in vaccine deliveries due 
to stock-outs at district store, stock-outs at the Provincial store, and lack of vehicles to transport 
vaccines to the facilities.  
The second study was conducted by Camara et al.18 in 17 health facilities in a rural district of 
Guinea, between March 2013 to 28th February 2014. This study described the occurrence of 
vaccine stock-outs at three-time points; before, during and after the Ebola outbreak. Vaccine 
stock-outs occurred in all the 17 facilities before and during the Ebola outbreak but reduced 
significantly to only two facilities after the outbreak. During the pre-Ebola period, vaccines 
affected were BCG, polio, pentavalent and yellow fever vaccines. Together, these vaccines 
contributed to a total of 2760 days of stock-outs. Out of these days, the BCG vaccine was the 
most affected, with 2121 (77%) days of the entire duration of stock-outs. During the Ebola 
outbreak, the total duration of stock-outs was slightly lower than the pre-Ebola period, with a 
total duration of 2706 days. During this period, BCG and Polio vaccines were most affected 
contributing to 1452 (54%) days and 916 (34%) days of the total duration of stock-outs. During 
the post-Ebola phase, only two facilities experienced stock-outs and a 99% reduction in the 
duration of stock-outs to 18 days. According to the authors, vaccine stock-outs experienced 
before the Ebola outbreak may have been caused by a lack of stock cards used to record and 
monitor stock levels of vaccines.18 
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Figure 5: PRISMA flow diagram showing the process of study selection 
 
 
The third study by Eboreime et al. 2015,19 conducted in Nigeria in 2013, reported stock-outs of 
the oral polio vaccine (OPV) and pentavalent vaccine from four provinces, in Nigeria. A total of 
1954 health facilities were assessed in two provinces each from the Southern and Northern 
regions of the country. From two provinces in the southern region, stock-outs occurred in 2.5% 
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(13/525) of facilities and 15% (95/622) facilities respectively. In the Northern region, stock-outs 
occurred in 1% (4/343) facilities and 2.4% (11/464) of facilities respectively.  
The fourth study reported stock-outs that occurred in two countries after vaccine introductions. 
Stock-outs of the newly introduced vaccines occurred in 51% of facilities in Kenya and 8% in 
Ethiopia 20.   
We further included stock-out reports of national surveys of vaccine stock-outs in primary health 
facilities in South Africa. The survey is usually conducted telephonically by an independent 
consortium of civil society organisations, under a project called Stop Stock Out Project (SSP). 
These surveys were conducted in 2013, 2014, 2015 and 2017.21–24. In 2013, 301 out of 2047 
(14.7%) of facilities that responded to the survey, reported stock-outs of at least one vaccine in 
the entire country’s immunisation schedule. The stock-out reports across each of the nine 
provinces were reported for years between 2013-2015 21–23 (Table 3 below).  The 2017 survey 
did not contain provincial summaries.  From the provincial reports, disparities occurred between 
provinces; in 2014, the pentavalent stock-outs were most frequently reported in Limpopo with 
28% (67/238) affected, while stock-outs of rotavirus vaccine was most reported in Eastern Cape 
where 10% (42/428) of facilities were affected. In 2015, 14% of facilities in the Eastern Cape 
experienced stock-outs of vaccines as compared to 7% in Free State (Table 3 below).23 
Between 2014 and 2017 the stock-out reports were based on three vaccines; rotavirus, DTP 
and measles. Within these years, there was a reduction in the proportion of facilities reporting 
stock-outs of these vaccines. For example, for the DTP vaccine (pentavalent or hexavalent), the 
proportion of facilities reported stock-outs reduced from 10% in 2014 to 4% in 2017(Table 4 
below).23,24  
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Table 3: The proportion of facilities reporting vaccine stock outs across the nine 
provinces in South Africa, between 2013 – 2015 21–23  
Province  `2013 survey 2014 survey 2015 survey 
Limpopo 35.6% 31% (73/238) 13% (32/248) 
Free State 32.2% 7% (9/138) 7% (10/135) 
Mpumalanga 15.5% 10% (7/173) 8% (18/220) 
Eastern Cape 12.5% 15% (64/426) 14% (64/469) 
Northern Cape 11.7% 8% (7/92) 7% (9/123) 
North West 9.9% 13% (26/201) 17% (37/223) 
Western Cape 9.5% 2% (4/245) 4% (13/326) 
Gauteng 8.5% 4% (11/252) 11% (31/277) 
KwazuluNatal 6.2% 10% (38/392) 14% (60/443) 
 
Table 4: Percentage of facilities reporting a vaccine stock out between 2014 and 2015 in 
South Africa# 
 
2014 2015 2017 
Rotavirus 6% (122/2194) 4% (91/2421) 4% (42/1078) 
DTP* 10% (219/2194) 9% (209/2428) 4% (46/1074) 
Measles 4% (78/2198) 3% (69/2425) 2% (24/1073) 
# 2016 report was not available  
* Pentavalent in 2014 and hexavalent vaccines in 2015 & 2017 
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2.4. Discussion 
One of the strategic goals of the WHO African region is to improve immunisation coverage. 
However, this goal will not be reached if vaccine shortages continue to occur and cause 
disruption of immunisation services at the service delivery level. Countries need an 
uninterrupted supply of vaccines at different levels in the supply chain, especially at the lowest 
level, if they are to reach the coverage targets set for their immunisation programmes 26. This 
review is important because identifying the magnitude and factors associated with vaccine 
stock-outs will enable policymakers to direct their efforts towards improving access and 
availability of vaccines at different levels of the supply chain 
2.4.1. The occurrence of stock-outs at the national and district level and 
its implications to immunisation services 
By 2020, it is expected that countries reporting on national level stock-outs will decline by 
67%.27 From the results obtained, it is evident that progress in the WHO African region is not on 
track to achieve this target.  When shortage of vaccines occurs at the national level, this often 
results in shortages of vaccines at the lower levels, 27 which consequently lead to interruptions 
in immunisation activities at service delivery level. Eventually, countries will fail to reach their set 
target for immunisation coverage, increasing the risk of pockets of disease outbreaks in the 
population 7,17. Depending on the duration, shortages of vaccines at the national level may not 
necessarily cause shortages at the district level or lead to interruption of immunisation services 
at service delivery points. Conversely, shortages at the district level can occur without shortages 
at the national level.  
It is also important to note that, the reports on stock-outs through the JRF are likely to 
underestimate the actual incidence of vaccine shortages at the district level and more especially 
at the facility level. This could be because the country managers reporting on the JRF may not 
have received reports from lower levels on stock-outs since many shortages at service delivery 
level are not reported. The service delivery level is an important level of reporting on stock 
shortages as this is a critical point and will determine whether or not the beneficiaries of the 
programme receive the life-saving vaccines. 
The incidence and duration of stock-outs are best measured at the lowest level in the supply 
chain. However, countries may not have adequate information systems to adequately report 
vaccine shortages and their duration, back up the supply chain. Hence the need for investments 
to strengthen logistics management and the information systems within the supply chain. There 
is a global consensus that safety stock should be maintained at three months level.14 Therefore, 
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the shortage at the national level, indicate that this safety stock gets depleted and the 
availability of stock in the lower levels in the supply chain is at risk 7. Furthermore, it is doubtful 
that in practice, a majority or a significant number of countries can keep stock of quantities that 
are in line with this safety level. This is because, since the introduction of more combination 
vaccines, the requirements for cold chain capacity has increased with an impact of the 
quantities that can be stored at each level of the cold chain and certainly at service delivery 
level.  
Major factors responsible for vaccine stock-outs at the national level and other levels of the 
supply chain include failure of the distribution system 7, poor forecasting and stock management 
issues in Gavi-eligible countries, delays with procurement in middle-income countries that are 
not eligible for Gavi support and global vaccine shortage in high-income countries.7,14,28 
Compared to other vaccines, BCG vaccines recorded the highest stock out rates at the national 
and district level, apart from the recent increase in shortages of polio vaccine. Shortage of BCG 
vaccine has been an ongoing global concern since 2013 due to decline in global availability of 
BCG in 201215. This was caused by manufacturing quality problems combined with high 
demand, resulting in global shortages.29 UNICEF, being responsible for procuring vaccines for 
most countries, experienced an increase in demand, especially from countries that previously 
self-procured their vaccines. In 2015, shortages worsened as the supply from UNICEF did not 
match the global demand.30 This explains why more countries in the WHO African region 
reported national-level stock-outs of BCG in 2015. However, an update from UNICEF states that 
the supply for 2016-2018 is anticipated to be sufficient enough to meet the demand by 
countries. This probably explains the slight reduction in the number of countries reporting 
national level stock-outs in 2016.31  
2.4.2. Vaccine stock-outs at the health facility level 
Our findings highlight the considerable gap that exists in the reports of stock-outs. It is known 
based on anecdotes, that vaccine stock-outs do occur, but the reports of vaccine shortages at 
facility level are scarce. From our results, South Africa is one of the few countries that seems to 
have a routine survey for stock-outs at the service delivery levels ongoing since 2013. 
Also, our results show that some district levels may be affected by stock-outs more than others. 
Therefore, variations do occur as illustrated in the reports from South Africa 21–23 and Nigeria 19. 
For example, in 2014 Limpopo Province, South Africa suffered most from stock-outs in the 
country than Gauteng Province, South Africa.  Similarly, the study from Nigeria also showed 
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some disparities between regions in the country with the Northern part of the country 
experiencing lesser stock-outs than the Southern region. The diffuse nature of the stock-outs 
shows that there are underlying reasons that differ by province 32. 
Reports of vaccine stock-outs must be taken seriously, no matter how short the duration may 
be. In 2015, 64 facilities out of 469 in the Eastern Cape Province of South Africa reported 
vaccine stock-outs. Although this may only be 14% of facilities, its impact can be significant. 
Each health facility is a unit, which serves a target population. This implies that stock-outs in 64 
facilities will impact on thousands of people that are meant to receive their vaccines from those 
facilities. That is, thousands of people, mostly children, are likely to miss their vaccinations, may 
not return for catch-ups and may eventually be prone to vaccine-preventable diseases. This 
explanation also applies to other results obtained in this study.  
The findings on the occurrence of stock-outs during Ebola outbreaks shows that it is crucial to 
ensure that there are no interruptions in routine immunisations in the face of disease outbreaks 
18. One factor that may have contributed to stock-outs of routine childhood vaccines during the 
Ebola disease outbreak could be a shift in priority, which may have influenced procurement, 
deliveries and the entire supply chain. Vaccine stock-outs due to outbreak of meningitis has 
been reported elsewhere.33 This highlights the importance of having safety stocks in the 
facilities as this helps to cater for unforeseen circumstances, especially in situations where 
supplies at the higher levels are not possible.34 
Introduction of new vaccines could also lead to stock-outs, as reported in the studies included in 
this review 17,20 and even elsewhere, in the Americas17. Stock-outs occurred probably due to a 
sudden increase in demand, which exceeded supply or in cases where catch-ups strategy are 
not being incorporated into forecasting predictions 20. 
A few limitations have, however, been observed in the included studies. Firstly, the method of 
data collection for the survey conducted in South Africa is prone to bias since it is done 
telephonically. The estimation of stock-outs using this method could lead to an underestimation 
of the exact frequency of stock-outs, and the respondents may not provide accurate information 
on vaccine stock levels.21–23 Also, the study conducted in Nigeria, which used secondary data, 
may not be completely accurate due to poor data quality.19  
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2.5. Conclusion and recommendations 
This study shows that significant levels of vaccine stock-outs still occur at different levels in the 
supply chain in many countries in the African region. With national-level stock-outs being able to 
cause an interruption in immunisation services at the facility level. Also, facility-level stock-outs, 
despite being underreported, still occur. The proportion of facility-level stock-outs can vary 
between provinces in the same country. Poor vaccine stock management, new vaccine 
introductions, disease outbreaks and delays in deliveries, poor supply chain structure and lack 
of skilled personnel can contribute to stock-outs at the facility level. More studies are needed to 
know the magnitude and extent of vaccine stock-outs. Also, there should be interventions 
targeting causative factors.  
African countries need to explore specific interventions for improving vaccine availability. For 
example, interventions to improve forecasting and stock management at all levels of the supply 
chain 35–40. Researchers need to identify, develop and evaluate innovations to enhance the 
availability of vaccines. This underscores the need to build the research capacity of countries in 
Africa 2. Countries need to assess and identify the factors that can help to prevent stock-outs in 
different areas, especially those areas most affected by stock-outs. Countries should strengthen 
immunisation supply chains via innovative ways of ensuring that the supply of vaccines to health 
facilities are without hassles. Such innovations need to allow for timely and consistent data 
visibility and availability. Furthermore, countries should take the process of effective vaccine 
management (EVM) more seriously. The EVM helps countries assess the performance of their 
vaccine supply chain (different areas of the supply chain) to identify strengths and weaknesses 
and ensure the designing and implementation of tailored plans to address the weaknesses. 
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3.0. Abstract 
Background 
Vaccine stock management includes the processes undertaken to ensure that vaccines are 
continuously available in the right quantities and quality at any point in time in the health 
facilities. Poor stock management has been identified as one of the causes of vaccine stock-
outs in health facilities. This study assessed the occurrence of vaccine stock-outs and vaccine 
stock management practices in primary health care facilities in OR Tambo district of the Eastern 
Cape province, South Africa. 
Method 
The descriptive cross-sectional study design was used in this study to assess both the stock 
management practices and the availability of vaccines in the facilities. The study was conducted 
in 64 primary health care facilities across all sub-districts in OR Tambo. Data were collected 
using a questionnaire administered by the researcher, record checks and through observation. 
The occurrence of stock-outs of six tracer vaccines on the day of the visit in the past 24 months 
were assessed. The data were captured into REDCap tool and analysed using STATA version 
14.  
Results 
Both stock cards and the stock visibility solution (SVS) device were used in all the facilities for 
vaccine stock management. The stock cards were mainly used for recording vaccine 
transactions while the SVS mobile device was used to report stock levels to the managers at 
district and provincial level. Less than half of the facilities visited 27 (44%) filled their stock cards 
regularly. Only about half 31(49%) of the respondents understood the concept of maximum and 
minimum stock levels, which are needed for proper quantification of needs. Delays in receiving 
supplies from the pharmaceutical depot were commonly reported by facilities, which could have 
contributed to stock-outs. Most of the facilities (77.6%) reported that the lead time was between 
one to three months. Common reasons for delays from the depot include staff shortages at the 
pharmaceutical depot causing a backlog of orders, delay from the suppliers, procurement 
delays and possibly lack of proper communication between the depot and the facilities. The first 
to expire first out (FEFO) principle was practiced in 41(73%) facilities.   
A total of 49 (77%) health facilities had at least one stockout for at least one vaccine on the day 
of the visit. Furthermore, BCG and OPV were the most commonly affected vaccines in 37 (58%) 
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and 28 (44%) of facilities, respectively. BCG and OPV had the most prolonged median duration 
of stock-out of 167 and 103 days, respectively. Amongst the newer vaccines, PCV had the most 
prolonged duration of stock-outs, with a median duration of stock-outs of 85 days. 
Conclusion  
The lack of proper stock management and the associated use of manual stock cards and long 
response time from the pharmaceutical depot may be responsible for stock-outs in the primary 
health care facilities in OR Tambo District. Interventions for improving vaccine availability should 
be considered. In particular, those focused on improving vaccine stock management, vaccine 
supply and human resources.  
Key words: Vaccine stock management, stock-outs, inventory, immunisation, South Africa 
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3.1. Introduction 
Vaccine stock management includes the processes undertaken to ensure that vaccines are 
continuously available in the right quantities and quality at any point and at all times in the 
vaccine supply chain, including health facilities. These processes include adequate forecasting, 
recording, monitoring of expiry dates, and proper storage of vaccines.1,2 Forecasting involves 
calculating the right quantities to order from the supplying store based on consumption rates of 
a health facility. The accuracy of quantities ordered depends on the quality of the records of 
consumption and an understanding by the person doing the calculation and relevant contextual 
factors.2 Indications are that a vast majority of primary health care facilities in South Africa still 
use stock cards to manage vaccine stock, and these can be used to obtain monthly usage data 
2. Accurate records of all stock transactions are essential in ensuring adequate quantities of 
vaccines throughout the vaccine supply chain.2 The recording and monitoring of expiry dates 
prevent vaccine wastage, while proper storage ensures that the potency of vaccines is 
maintained. The national department of health of South Africa published the “Cold Chain and 
Immunisation Operations Manual, 2015 edition” which is a guideline on standard practices for 
the management of the vaccines at different levels in the supply chain, including the health 
facilities. This is a standard national guide for every health worker who is in charge of managing 
and handling vaccines.2  
Poor stock management has been identified as one of the causes of vaccine stock-outs in 
health facilities.2–5 The complete absence of vaccines at the point of service delivery, which is 
referred to as vaccine stock-out6 is one of the serious challenges that threaten the success of 
immunisation programmes.3–5,7–10 Vaccine stock-outs occur more often and have more impact 
on populations that dwell in rural areas; the majority of them depend on the public health system 
for their health care needs.11–13 Vaccine stock-outs result in repeated and costly visits to health 
care facilities by health care users before they can access the vaccines. These repeated visits 
can cause a loss of public confidence in the health system.14 Furthermore, the children who do 
not receive their vaccine doses timely are prone to vaccine-preventable diseases, and their 
communities are also at risk of disease outbreaks.3,4,15  
There are a few reports that point to significant shortages of vaccines which became more 
common since the introduction of new vaccines in many parts of South Africa 3,16. However, 
despite these reports, there is limited information on the actual shortages of vaccines; especially 
in certain parts of the country such as the Eastern Cape Province. Specifically, there is no 
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literature on the level of availability and stock management of vaccines in OR Tambo district of 
the Eastern Cape Province, one of the most rural districts in the country. 
This study assessed the availability of vaccines and vaccine stock management practices in 
primary health care facilities in the OR Tambo district. This chapter describes the status of 
vaccine stock management at primary health care facilities in OR Tambo district, Eastern Cape. 
This study intends to add to the body of knowledge that will be relevant to inform policies around 
improving stock management and ultimately preventing vaccine stock-outs. 
 
3.2. Objectives of this study 
i. To assess the vaccine stock management procedures used in selected facilities in OR 
Tambo district of the Eastern Cape Province of South Africa. 
ii. To establish the level and frequency of vaccine stock-outs in OR Tambo district  
To identify the vaccines more likely to be out of stock. 
3.3. Methods 
3.3.1. Study setting  
This study was conducted in the OR Tambo district of the Eastern Cape Province. The Eastern 
Cape is located on the east coast of South Africa and has eight districts. The Eastern Cape 
province is the second largest in South Africa and one of the poorest 17,18. The 2016  estimates 
are that 20.8% of the 7 061 700 population of the province lives in OR Tambo District 17. This 
district is comprised of four sub-districts; is rural and one of the poorest districts in the country 
17. OR Tambo district depicts a typical resource-constrained area. The district also has a poor 
terrain, inadequate infrastructure and because of this access to some health facilities is a 
challenge, even for the health workers.  
OR Tambo district has a high neonatal and child mortality and a high burden of HIV/AIDS and 
TB.  Various initiatives have been implemented to improve provision and the quality of health 
care services in the district. Some of these initiatives include the e-health strategy, supply chain 
management reforms, ideal clinic realisation. It is one of the National Health Insurance (NHI) 
pilot districts in South Africa.  
The supply chain structure in the Eastern Cape is mostly the pull system, whereby facilities 
send requisitions or place orders to the pharmaceutical depot based on consumption rates.  
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Figure 1: Map of the Eastern Cape Province showing districts and sub-districts 
(https://municipalities.co.za/provinces/view/1/eastern-cape) 
 
3.3.2. Participants 
The sites for data collection were mainly the primary health care facilities where immunisation 
services are provided. Respondents for this study were nurses, pharmacists and pharmacist 
assistants who are employed on a full-time basis at each selected facility and involved in the 
management of vaccines. Each respondent represented a facility. Student nurses and private 
PHC clinics and their employees were excluded from this study. 
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3.3.3. Sample size calculation 
Based on the District Health Information System (DHIS), OR Tambo is comprised of 145 health 
facilities.  We calculated a total sample size of 60 based on a hypothesised overall stock out 
rate of 50%, with a confidence interval width of 95% and 10% precision.  
3.3.4. Sampling  
We used probability random sampling to sample 64 sites proportional to the number of facilities 
in each sub-district. A total of 64 sites were visited: 21 facilities in King Sabata Dalinyebo (KSD); 
23 in Nyandeni; 7 in Quakeni and 13 in Mthlontlo. 
3.3.5. Study design 
We conducted a cross-sectional study to assess both the stock management practices and the 
availability of vaccines in the facilities. Retrospective record review of stock-cards was used to 
check for stock-outs that occurred in the last two years.  
3.3.6. Outcome measures  
The following outcomes were measured: 
• The proportion of facilities that reported to various stock management practices such as 
recording and reporting systems, storage practices, management of damaged or wasted 
vaccines  
• The occurrence of vaccine stock-outs: This was measured as the percentage of facilities 
that experienced a stock-out of one or more vaccines during the study period, precisely the 
day of the visit to the health facility. The result was expressed as a percentage of the total 
number of facilities [8]. 
• Duration (in days) of vaccine stock-outs over two years: February 2017 – February 2019. 
Duration of stock-outs was calculated from the day the vaccine was not available until the 
day the new vaccine stock was obtained or the day of the visit. 
3.3.7. Data collection and Logistics 
Before data collection, the researcher and a co-investigator conducted a visit to the Eastern 
Cape province to brief and enlist the support of senior managers on the planned study. The visit 
was also to assist with the refining of the research questions and the questionnaire that was 
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used for data collection. The visit was conducted over four days from May 28 to 31st 2018. 
Meetings were held with Provincial senior managers. All four sub-districts were visited, and the 
study was introduced to programme managers. Four facilities were visited, each from one of the 
sub-districts. This exercise was useful in further planning, and several areas were clarified, 
which related to the research and was incorporated into the study and the questionnaires. 
During site selection, we excluded the facilities visited before the main study, to minimise bias. 
Also, the officials in the visited facilities neither had access to the questionnaires nor knew the 
information that will form part of the research questions.  
Data was collected between 25th February to 15th March 2019. Data on vaccine stock 
management procedures in the facilities were collected using questionnaire and physical 
observation of vaccine stock management procedures in the participating clinics. The 
questionnaire was adapted from the WHO effective vaccine management (EVM) assessment 
tool 19 (Appendix 2). The questions on stock management procedures focused on following 
areas; procedures used for stock recording, vaccine ordering, managing and recording of 
damaged and expired stock, the frequency of inventory, storage arrangements and availability 
of vaccines.  We also checked the vaccine stock records, stock at hand and records of vaccine 
orders. We verified if the stock cards were consistently used for stock management. The stock 
cards were also checked to see if they reflect: minimum or re-order level, maximum and current 
stock levels and vaccines received and issued. Vaccine stock-outs data were collected through 
physical counts of the six tracer vaccines in the fridges. The vaccines were Bacillus Calmette 
Guerin (BCG), measles, rotavirus (RV), pneumococcal conjugate vaccine (PCV), oral polio 
vaccine (OPV) and hexavalent vaccine, a combination of Diphtheria, Tetanus, Acellular 
Pertussis, Inactivated Polio Vaccine, Haemophilus influenza type b, Haemophilus influenza type 
b and Hepatitis B (DTaP-IPV-Hib-HBV). We assessed the availability of vaccines on the day of 
visit to the facilities. We also assessed the duration of stock-outs in the last two years (Feb 2017 
– Feb 2019). The initial plan was to assess the occurrence of stock-outs and duration at least 
three years before and after the introduction of the SVS in order to assess the effects of the 
SVS on vaccine availability. Unfortunately, we could not find most of the previous years’ bin 
cards. Since most facilities had at most two years records, we had to work with what we got.  
3.3.8. Data Management 
Data sets from questionnaires were stripped off all personal information upon completion of data 
collection. Study data collected on the questionnaire was managed using Research Electronic 
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Data Capture (REDCap) tool hosted at the South African Medical Research Council. REDCap is 
a “secure, web-based application designed to support data capture for research studies.20 
 
3.3.9. Data analysis 
Data from REDCap was exported to STATA statistical software, version 14, for analysis. Data 
were analysed using descriptive analysis. Association between variables was determined using 
the chi-square test. The continuous variables such as duration of stock-outs were summarised 
using median since they were not normally distributed. The categorical variables were 
summarised using frequencies.  
We tested the following hypotheses (Null hypothesis), at p<0.05 level of significance  
i. There is no difference between the proportion of facilities that reported stock-outs 
of vaccines across the districts and what?? We should be comparing at least 2 
things. Refer to Chapter 1 comments. 
ii. There is no association between the presence of pharmacy personnel and the 
occurrence of vaccine stock-outs 
 
3.3.10. Ethical consideration 
Before data collection, ethics approvals from the Research Ethics Committee of the Faculty of 
Medicine and Health Sciences, Stellenbosch University (S18/08/154), from the Eastern Cape 
Province Department of Health (EC_201810_009) and OR Tambo district.  In each facility 
visited, we sought the consent of participants before collecting data.  
Data sets from questionnaires were stripped off all personal information to maintain 
confidentiality.  
3.4. Results 
3.4.1. Response Rate  
A total of 64 selected public health facilities were visited. Although we had two facilities that 
declined to participate, they were replaced with other facilities closest to them. Therefore, the 
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overall response rate for this study is 100% (64/64). Table 1 below shows the number of 
facilities visited per sub-district. 
Table 1: Number of facilities visited in the OR Tambo district  
 
Sub-district Number of facilities visited 
KSD 21 (32.8%),  
 Nyandeni  23 (35.9%)  
Quakeni  7 (10.9%) 
Mthlontlo 13 (20.3%) 
 
3.4.2. Characteristics of facilities visited in OR Tambo district 
All four sub-districts in OR Tambo which have a total of 146 facilities participated in the study. 
Table 2 shows other characteristics of the facilities visited; the position of respondents, 
pharmacy personnel and the type of storage equipment used.  There was a total of 28 (44%) 
pharmacist’s assistants in all the facilities visited, 2 (3%) pharmacists and 34 (53%) were nurses 
who were vaccinators or facility managers. Districts with more facilities had more pharmacy 
assistants. For example, 23 facilities were visited in Nyandeni, and this district had 11 
pharmacist’s assistants.  
 
 
 
 
Stellenbosch University https://scholar.sun.ac.za
58 
 
Table 2: Characteristics of facilities visited in OR Tambo district 
 
Pharmacy personnel Position of respondents Type of storage equipment 
Sub-district Pharmacist 
Pharmacy 
assistant Both None 
Pharmacist’s 
assistant Pharmacist Vaccinator 
Facility 
manager 
Vaccine 
fridges 
(chest like) 
Vaccine 
fridges 
(upright) Glassdoor 
Ordinary 
domestic 
KSD 
 0 7 1 13 6 1 12 2 5 4 0 
11 
Nyandeni 
  0 11 0 12 9 0 8 6 6 2 0 
9 
Quakeni 
 0 4 0 3 4 0 1 2 3 1 1 
3 
Mthlontlo 1 6 0 
              
6 5 1 4 3 3 8 0 
3 
Overall 
Facilities n(%)      1 (2%) 28 (44%) 
1 
(2%) 
34 
(53%) 24(3%) 2 (3%) 25 (39%) 
13 
(20%) 17(27%) 
15 
(23%) 1 (2%) 
36 (56%) 
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3.4.3. Stock management practices 
 
Recording and reporting systems and practices  
 
Both stock cards and the stock visibility solution (SVS) devices were used in all the facilities for 
capturing vaccine stock levels. The stock cards were used to record vaccines movement and 
utilisation while the SVS mobile device was used to report on stock levels to the managers at a 
higher level, mainly provincial level. Only one facility was found to be using a desktop computer 
to capture vaccine stock.  
The stock cards had sections for the following information: name of the vaccine, dosage form, 
and strength, quantity ordered, requisition number, to/from where orders were received or 
transferred to, quantity received, quantity issued, stock balance, unit price and remarks (Figure 
1). They also have sections for re-order level, and total monthly issues and consumption levels. 
However, stock cards did not have fields for recording batch number, expiry date and VVM 
status of vaccines in keeping with the standard set in the Cold Chain Manual. Less than half of 
the facilities visited, 27 (44%) filled their stock cards regularly, at least up to one week before 
the study. Only nine (14%) facilities had physical stock closely matching with stock on the stock 
cards. Approximately half (49%) of the facilities had separate stock cards for measles vaccine 
and its diluent. 
Furthermore, only 26 (43.3%) facilities recorded expiry dates and 32 (50%) facilities recorded 
batch numbers of vaccines. Even though there were no fields for bath number of vaccine vials, 
on the stock cards, some facilities made use of the ‘remarks section’. No facility had records of 
the VVM status of vaccines on their stock cards because the provision was not made for this 
information on the stock-cards. There was no other record that indicated the VVM status of 
vaccines.  
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Figure 1: Photo of the stock card used in all facilities in the Eastern Cape Province, 
South Africa.  
Knowledge and record of maximum and minimum stock levels on the stock cards 
Among facilities visited, 31(49%) of respondents understood the concept of maximum and 
minimum stock levels. Furthermore, it was observed that 24(39%) and 25(40%) of facilities, 
recorded minimum and maximum stock levels on stock cards, respectively. 
Vaccine ordering and lead/response time  
The requisition booklets were used in all the facilities for placing orders to the pharmaceutical 
depot. We sought their responses regarding the response time, that is, how long it took for the 
facilities to receive supplies from the pharmaceutical depot once an order is placed. Facilities 
reported they experienced delays: 45 (77.6%) facilities reported that lead time took between one 
to three months; 10 (17%) reported that their lead times ranged between two to three weeks. All 
facilities reported that they placed an emergency (‘special’) orders while waiting for their main 
supplies from the depot. Special orders that are generally for a maximum of five items are 
usually placed whenever there is an urgent need for items while waiting for bulk orders to be 
supplied by the depot. The working norm is that a person from the facility placing a special order 
goes to the depot to pick and collect the special order. As a result, special orders were received 
on the same day. Also, some facilities had to send their pharmacist’s assistants to pick their 
bulk orders. If this did not happen the lead time was longer than two or three months. It was 
observed that a majority of facilities place special orders weekly and, in many facilities, the 
understanding and the standard was that special orders are routine and are placed weekly.  
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Twenty-six (42%) facilities reported that the quantities they ordered were sometimes reduced by 
the depot. The vaccines mostly reduced were BCG and OPV. Other vaccines were reduced 
depending on the availability at the depot. Also, in most instances, they do not receive matching 
quantities of measles vaccine and the diluent.  A few facilities did not know that they had to 
order measles diluent separately. 
Reasons for long response times from the pharmaceutical depot 
On the issue of long response time from the depot, we had a conversation with the staff of the 
depot. They highlighted the following reasons why facilities experience delays with their orders; 
the primary reason is the backlog of orders at the depot. These backlogs are caused by staffing 
issues. The discussion elicited that the depot was experiencing staffing challenges coupled with 
the ongoing renovations, which made working conditions a challenge. The staff shortages 
generally meant that the facilities had to send their pharmacist’s assistant or someone to the 
depot to do the picking of vaccines, and if this did not happen the delays will be much longer 
than two months or more.  
Another concern expressed by the depot officials was the ‘erratic’ orders from the facilities. The 
facilities make inconsistent orders, sometimes very high and sometimes low, which could be 
attributed to their inability to calculate their maximum and minimum stock levels. Also, some 
facilities tend to order in excess from the depot when there are issues of undersupply to the 
depot. As a result, the stock levels at the depot may not be enough to serve other facilities. 
Delays were also caused by shortages from the suppliers. Other reasons reported were delays 
in procurement on their part, which relates to the staffing issues. Furthermore, the electronic 
stock management system malfunction sometimes occurs, causing delays in procurement by 
the depot and eventually resulting in longer response time for the facilities. The depot staff 
highlighted a gap in communication between the depot and the facilities as one of the 
contributing factors for delays and inefficiencies in supplying the facilities with their needs.  
3.4.4. Assessment of storage practices in the facilities  
Upon observation, the first to expire first out (FEFO) principle was practiced in 41(73%) 
facilities.  Of the 36 facilities that use domestic fridges, 8(22%) store vaccines in the vegetable 
drawer. There were expired vaccines in 6 (11%) of facilities. The vaccines that had just expired 
and were mostly the hexavalent vaccine. Eleven (20%) facilities had frozen vaccines whereas 9 
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(15%) facilities had vaccines that had reached the VVM discard point. Most of the frozen 
vaccines were in the domestic fridges. The quantities of measles vaccines and their 
corresponding diluents matched in 16 (29%) facilities. In one facility rabies vaccine was stored 
in the freezer.  
3.4.5. Disposal of Damaged or expired stock  
When the respondents were asked if they knew the procedure to follow for managing vaccine 
wastage, half 32(51%) reported that they knew how it is done. Thirty-seven facilities (59%) 
reported that they had records of wastages. However, upon verification, only a few (how many) 
facilities had reports of vaccine wastages in the previous year.  
When the respondents were asked to explain the procedure of managing damaged vaccines, 
there were varied responses. Most of them reported that they filled the ‘incident form’ firstly 
before disposing the expired or damaged vaccines into the waste bucket which were picked up 
by a private waste disposal company. Other respondents said they would phone the district 
pharmacist who would pick damaged items up, after filling the waste indicator forms and 
disposing into the waste bucket. Most of them reported that they hardly experienced wastage; 
they experienced stock-outs more than wastages. We also asked if they knew how to calculate 
vaccine wastage, 30(49%) said they did. Also, 38(67%) facilities reported that they did not know 
that they were supposed to report wastages to managers.  
3.4.6. Availability of vaccines in the facilities in OR Tambo district 
A total of 49 (77%) health facilities had at least one stockout for at least one vaccine on the day 
of the visit. Furthermore, BCG and OPV were the most commonly affected vaccines with 37 
(58%) and 28 (44%) facilities seen to have experienced the stockouts of these vaccines, 
respectively, on the day of the visit. Amongst the newer vaccines, nine (14%) of facilities had 
RV stock-out while eight (13%) facilities had stock-outs of measles vaccines on the day of the 
visit. However, in the last two years (February 2018-February 2019), apart from BCG and OPV 
having the longest median duration of 167 and 103 days, respectively, PCV experienced the 
longest duration of stock-outs of 85days, amongst the newer vaccines. Table 5 shows the 
median duration of vaccine stock-outs in the affected facilities.  
Table 2 shows the occurrence of vaccine stock-outs on the day of the visit of across each sub-
district. KSD had the highest percentage of facilities occurrence of 86%, while Quakeni sub-
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district had the lowest occurrence, of 29%. However, Pearson’s chi-squared test for the 
difference in the occurrence of stock-outs across the sub-districts yielded a p-value of 0.02. We, 
therefore, reject the null hypothesis. This implies that there is a significant difference in the 
occurrence of vaccine stock-outs across the sub-districts.  The differences observed could be 
attributed to the different sample sizes for each sub-district. The sub-districts with high number 
of facilities visited experienced more stock-outs.  
The Pearson’s chi-squared test for association between the presence of pharmacy personnel 
(pharmacy assistant or pharmacist or both) and the occurrence of stock-outs yielded a p-value 
of p = 0.3. Hence, we fail to reject the null hypothesis. Therefore, there was no association 
between the occurrence of vaccine stock-outs and the presence of any pharmacy personnel. 
Surprisingly, the sub-district with the higher number of pharmacy assistants, which one, mention 
it experienced more vaccine stock-outs.  
 
Table 3: Percentage of facilities reporting stock-outs per sub-district on the day of visit 
 
Sub-district  
Total number of facilities (N) 
n (%) 95% CI 
KSD 
(N=21) 
18(86) 63-96 
Nyandeni 
(N=23) 
19(83)  61-94 
Sub-district 3  
(N=7) 
2(29)  6-70 
Sub-district 4  
(N=13) 
10(77)  46-93 
Overall stock out n (%) 
 
49 (77) 64 – 86 
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Table 4: occurrence of vaccine stock-outs in the facilities on the day of visit 
 
Vaccine Number of facilities with 
stock-outs 
Percentage of facilities 
(95% CI) 
BCG 37 58% (45-70) 
Measles vaccine  8 13% (6-23) 
Rotavirus vaccine (RV) 9 14% (7-25) 
Pneumococcal conjugate vaccine 
(PCV) 
3 5% (1-13) 
Hexavalent 3 5% (1-13) 
Oral Polio vaccine (OPV) 28 44% (32-56) 
 
 
 
 
Table 5: Duration of stock-outs of vaccines in the primary health facilities in OR Tambo in 
the last two years (Feb 2017 – Feb 2019). 
Vaccine Median days  Interquartile range, Q1-Q3 
BCG 167  71-299 
Measles 44  1-74 
Rotavirus 61  21-80 
Hexavalent 72  27-151 
PCV 85  33-140 
OPV 103  60-210 
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3.5. Discussion 
According to the WHO, the concept of an ideal vaccine stock management system is one that 
ensures that vaccines are of assured quality when they are received, are always in the right 
quantities at all times and stored appropriately with proper maintenance of the cold chain.1 This 
study describes the stock management practices in primary health care facilities in OR Tambo 
district, Eastern Cape, as well as the occurrence of vaccine stock-outs.  
This response rate achieved in this study is in line with the 2014 Stop Stockout Project (SSP) 
survey conducted in South Africa, where 98% responded to the survey as compared to 100% in 
this study.14 This high response rate increases the validity and generalizability of the findings to 
the entire district.21  
Our findings on the status of vaccine availability in the primary health facilities in the study area 
indicate that a high proportion of facilities experience vaccine stock-outs. These level of stock-
outs in this study(on the day of visit) at  77% of facilities that experienced stock-outs is higher 
than that of another study conducted in another province in South Africa, where 29% of facilities 
experienced vaccine stock-outs.3 Other countries have also reported a much lower proportion, 
such as 8% in Ethiopia;  51% in Kenya22 and 6.7% in Tanzania.23 Similarly, our findings are 
much higher than those of the stop stockout project (SSP) in the Eastern Cape, where the 
authors used a different method. According to the SSP 2016 reports, 14% of facilities in the 
Eastern Cape reported stock-outs of vaccines on the day the telephonic survey.16  However, the 
methodology of this study of phoning and enquiring about stock out on that particular day can 
be expected to show a much lower shortage.  
The proportion of facilities that reported stock-outs of hexavalent vaccine in this study (5%) is 
almost similar to that of the 2017 report by the SSP24. However, the occurrence of stock-outs of 
rotavirus (4%) and measles vaccines (2%) as reported by the SSP in 2017 are much lower than 
in this study where we found 14% and 13% respectively. The stock-outs data from this study 
was based on physical counts, while the SSP was based on a telephonic survey. The most 
affected vaccines are BCG and OPV, and other studies have reported the same.25 The stock-
out of BCG should be related to global shortages that have been ongoing since 2012 due to 
problems with procurement problems combined with high demand.26,27 
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With regards to stock management, most of the facilities visited seem to be reluctant to fill the 
stock cards.  A vast majority of stock cards were not updated; minimum and maximum stock 
levels were neither recorded on the cards nor used as a basis for ordering of vaccines. Most of 
the participants lacked adequate knowledge of the standard procedure for ordering vaccines.  
Although not explicitly asked in many facilities, there was an indication that few pharmacist’s 
assistants had special training on vaccine management. According to the national department of 
health cold chain manual, the minimum levels and maximum levels of vaccines need to be set 
for every vaccine in order to adequately quantify needs and aid in determining quantities to 
order2. The minimum stock level is the level below which vaccine stocks should never drop 
without having placed an order. It is the amount of stock that will be used in the time between 
placing and receiving an order plus the reserve or safety stock that is kept for emergencies and 
unanticipated demand or delivery delays.2,28 Setting the minimum stock levels for every vaccine 
guards against experiencing shortages or stock-outs in the facilities.  The maximum stock level, 
on the other hand, is set to guard against oversupply, which results in losing vaccines to 
expiration before they can be used. The maximum stock level is the amount needed to meet 
demand until the next order is received, taking into account factors that play out between 
placing of orders and receiving them. For example, lead time, delays etc.2 Both maximum levels 
and minimum stock levels are calculated from historical stock data, which is usually obtained 
from the stock cards. When stock cards are not regularly updated, such data is not available, 
and the facility runs the risk of stock-outs or overstocking. There are also other reports that 
health facilities are not able to quantify their needs and keep updated stock records.13,29–32 It 
may, therefore, be necessary for policymakers to consider replacing the stock cards with 
electronic stock management systems such as the Rx solution which is mostly used in 
hospitals. The Rx solution has advantages over the paper-based system of stock management. 
With electronic stock management, there is better tracking of stock movement, including batch 
numbers and expiry dates of medicines. Also, there is automated ordering of vaccines; the Rx 
solution can automatically recommend quantities of items to be ordered based on historical 
data,33–35 which is not easily obtainable with the stock cards. This can solve the challenges of 
improper forecasting. It will be essential to harmonise the functions of both the Rx solution with 
the SVS to avoid duplication of efforts for health workers; by designing a single system for stock 
management in the facilities and reporting of stock levels to the managers.   
The depot faces some challenges which complicate the challenges faced by the facilities and 
the weakness of the system, resulting in delays in delivery of the supplies to facilities. The 
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facilities reported that there are frequently delays in the delivery of supplies from the depot.  It 
appeared that facilities that had transport and had a pharmacist’s assistant to go to the depot to 
pick their orders were in a better position to ensure the adequacy of stock. However, this 
information was not specifically asked for, and this could not be analysed. In some instances, 
their supplies are reduced by the depot. The staff at the pharmaceutical depot highlighted that 
the depot suffers staff shortages which have led to backlogs of orders from the facilities and 
hence may not be able to meet up with the demand from the facilities. Secondly, delays could 
be caused by shortages experienced by the suppliers.  
The depot confirmed the reduction of orders sent by the facilities and the reason is that they 
perceive that the facilities order more than their needs, in anticipation of stock-outs. The depot 
reduces orders in order to conserve stocks and ensure that the available stock is enough for 
other facilities. Excess ordering could occur when there is a sudden increase in demand from 
the facilities, in cases of outbreaks, for example, where the facilities will need to perform 
immunisation campaigns. All the issues highlighted above, including staff shortages, 
adjustments of quantities ordered by facilities (which was also reported in a  previous study 
conducted in this same depot in 2013), imply that these challenges have been persistent.36 A 
qualitative study conducted in one of the provinces of South Africa highlighted a gap in 
communication as one of the factors that influence stock management in the health facilities.37 
The communication between the depot and the facilities must be strengthened in order to solve 
these challenges.  
Human resource constraints can have been identified to be one of the significant causes of 
supply chain-related problems,38 including poor stock management.3,39–41 This is probably one of 
the reasons for poor stock management noted in this study. Vaccine stock management was 
handled by nurses in facilities where there were no pharmacy assistants. As with other studies, 
there were more facilities with nurses responsible for pharmaceuticals, and fewer had pharmacy 
assistants in the facilities visited.3,37,42 Generally, nurses were not trained in vaccine stock 
management; they might have been merely orientated. 
The issue of nurses taking up the responsibility of managing pharmaceuticals is a challenge 
because it interferes with their primary clinical duties in the facilities. Nurses feel overwhelmed 
by the excess workload that comes with management of pharmaceuticals.3 It is therefore 
essential to recruit more pharmacist assistants who will be dedicated to the stock management 
of vaccines and other medicines. On the other hand, the policymakers may consider proper 
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training and refresher training for the nurses on the management of pharmaceutical. Such 
training should have specific focus on management of vaccines since these have specific 
qualities and requirements. One option could be to include management of pharmaceuticals as 
part of the compulsory professional development for nurses.37  
Vaccines are meant to be administered well before their expiry date is reached. The vaccines 
and diluents must be arranged in such a way as to maintain the FEFO stock management 
system.2,28 Most facilities understood and adhered to this principle as compared to another 
study where none of the facilities was adherent.43 There were more domestic fridges than the 
vaccine fridges in the facilities visited, as it is the case in most facilities in South Africa.2 The 
number of domestic fridges in the facilities was more than what was reported in another study 43 
The use of the domestic fridges may be why some facilities visited had frozen vaccines. All 
facilities ideally should be using the standard vaccine refrigerators, but when domestic fridges 
are used, it is expected that the temperatures be monitored continuously.2 Domestic fridges are 
being used in primary health care facilities probably due to lack of resources, but policymakers 
must invest in proper storage equipment to avoid accidental freezing seen in some of the 
facilities visited. 
3.6. Conclusion 
Significant stock-outs occur in the primary health care settings in the OR Tambo district. These 
stock-outs could be linked to poor vaccine stock management, particularly in the area of record-
keeping and quantification of needs. Stock-outs caused and aggravated by long lead times 
experienced by the facilities and a gap in communication between the supplying depot and the 
facilities. There is a need to explore multipronged interventions that could be used to improve 
vaccine stock management in primary health care facilities. These interventions should target 
the entire supply chain system, human resource and tools used for stock management in the 
facilities.  
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4.0. Abstract 
Introduction 
One of the challenges facing the success of immunization programmes is shortages of vaccines 
at health facilities, which could result from inadequate vaccine stock management. Several 
approaches have been designed by countries to improve vaccine stock management. This 
review summarises currently available information on interventions for vaccine stock 
management.  
Methods 
We considered both randomised trials and non-randomised studies eligible for inclusion in this 
revew. The following databases were searched: PubMed, Embase, Cochrane Central Register 
of Controlled Trials, World Health Organization Library Information System, Web of Science, 
PDQ-Evidence. We searched the websites of the World Health Organisation, Global Alliance for 
Vaccine and Immunisation, PATH Vaccine Resources Library, and United Nations Children’s 
Fund. The reference lists of all the included studies were also searched. Two authors 
independently screened search outputs, reviewed full texts of potentially eligible articles, 
evaluated risk of bias, and extracted data; resolving disagreements through consensus.  
Results 
Four studies met our inclusion criteria (three before-after studies and one randomised trial). 
Three studies were conducted in low- and middle-income countries, while one was conducted in 
Canada (a high-income country). All the studies had various limitations and were classified as 
having a high risk of bias. Study findings suggest that use of digital information systems to 
improve information and stock visibility, coupled with other interventions (such as training of 
health care workers on the use of innovative tools and redesign of the supply chain to tackle 
certain bottlenecks) have the potential to increase vaccine availability, reduce response times, 
and improve the quality of vaccine records. 
Key words: Vaccine stock management, vaccine stock-out, vaccine availability, primary health 
care facilities, e-health, supply chain 
 
 
Stellenbosch University https://scholar.sun.ac.za
76 
 
 
4.1. Introduction 
Vaccine supply chains play an important role in ensuring functional immunisation services and 
are therefore an important element of ensuring access to primary health care services 1. The 
vaccine supply chain is fundamental to a good health system, and it should be designed to 
ensure consistent and uninterrupted supply of vaccines 2. However, many children, especially in 
low and middle-income countries, do not always get vaccines when they present to health 
facilities 3,4. Shortages of vaccines at service delivery points have serious consequences for the 
healthcare system and its users. Vaccine shortages undermine the commitment by many 
countries to the benefits of life-saving vaccines and universal access to quality primary 
healthcare services5.  
Immunisation programmes in many countries are currently characterized by new vaccine 
introduction and efforts by countries to improve vaccine coverage 6. While the introduction of 
new vaccines is a progressive step towards achieving the Sustainable Development Goals for 
health; it creates new challenges. A smooth introduction of new vaccines, which often is an 
expansion of national schedules with additional antigens, demands upgrading of systems, 
processes and infrastructure. However, in many countries, these upgrades are not in place 
before new vaccines are introduced.  
New vaccines place a huge demand on cold chain capacity. For example, in Ethiopia, the 
introduction of pentavalent, pneumococcal conjugate and rotavirus vaccines resulted in a five-
fold increase in cold chain capacity requirement7. Some low and middle income countries 
(LMICs) have reported a 10-fold increase in value of vaccines5. Many LMICs have vaccine 
supply chains and management systems that over decades have remained unchanged, with no 
corresponding increase in capacity and with no upgrade of the technology and information 
systems 7,8.The interplay of these factors, which includes: increased cold chain requirements, 
the increase in contextual factors such as increase in targeted populations as well as a 
significant number of outreach (mobile) service points require vigilance in management of 
vaccine stock, to avoid vaccine shortages at service delivery points. Effective management of 
vaccine supply chains may be better achieved with the support of technology and upgrade of 
other systems. It is due to these underlying factors that several countries experience vaccine 
shortages with the introduction of new vaccines9–11. 
Vaccine stock-out is said to occur when there is complete absence of a particular vaccine or 
different vaccines12. The frequency and duration of stock outs are indicators commonly used to 
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measure vaccine availability 13. When stock outs occur, children often miss their vaccinations 
which in turn reduces immunisation coverage14. In LMICs,  vaccine stock outs are usually 
caused by poor stock management which includes poor recording of vaccine inventory, poor 
forecasting of demands, delays and or mistakes when placing orders as well as failure to 
establish actual stock levels before placing orders 14,15.  
To improve vaccine availability at health facility level, detailed and correct information on stock 
levels and information on other records are required 14. Innovations in the vaccine supply chain 
are  critically needed to reduce vaccine stock-outs 16, and to this effect, countries have designed 
approaches to improve vaccine stock management. One of such innovations is the use of digital 
tools to improve information or visibility of vaccine stock within the supply chain. These devices 
readily provide information such as: stock-on-hand and the quantity received, dispensed, and 
wasted 17. For example, dash boards and mobile devices are used by LMICs to improve vaccine 
stock management and also monitor vaccine availability 18–20. Other interventions that have 
been used to improve vaccine stock management include redesigning the supply chain and 
training of health personnel21. This scoping review is aimed at identifying and assessing the 
effectiveness of interventions for improving vaccine stock management in primary healthcare 
facilities. To the best of our knowledge, no review has been conducted to assess the 
effectiveness of these interventions.  
4.2. Methods 
4.2.1. Inclusion criteria 
This review was registered in the International Prospective Register of Systematic Reviews 22 
and the protocol was published in a peer-reviewed journal23.  The following study designs were 
eligible for inclusion in this review, randomized trials (with randomization at either individual or 
cluster levels), controlled before-after studies, interrupted time series studies and repeated 
cross-sectional studies with no restrictions on language and publication status. The target 
population is healthcare facilities where vaccines are administered, and healthcare workers 
involved in providing immunisation services.  
We considered the following interventions in our inclusion criteria:   
• Interventions directed at providers of immunisation services such as education or training, 
audit and feedback, use of prompts and reminders, and supportive supervision. 
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• Interventions for monitoring vaccine stock level at facilities e.g. using mobile devices 
including hand held devices and cellular phones or hotline platforms. 
• Interventions targeting the health system offering immunization services such as re-
designing vaccine supply chain system, and integration of interventions with other services. 
• Other interventions intended to reduce vaccine stock-outs, including multi-component 
interventions.  
We considered the following as eligible comparisons: standard vaccine stock management 
practices in the study setting, alternative interventions, and similar interventions implemented 
with different degrees of intensity. We were cognizant of the fact that a standard vaccine stock 
management practice in one context may differ in another setting. 
Our primary outcomes of interest were as follows: 
• Vaccine availability: The proportion of vaccination days in which all vaccines in the 
national schedule were available, and no one eligible for vaccination was turned back 
because of stock out of vaccines, i.e. did not reach zero-stock or as defined by the 
authors. 
• Stock-outs: The percentage of facilities that experienced a stock-out of a specific 
vaccine(s) that a site is expected to provide, at any point, within a defined period. 
We also considered the following as our secondary outcomes: 
• Inventory accuracy rates: The accuracy of data on product stock levels at a facility; that 
is, a measure of how stock balances recorded on a stock ledger, stock cards or 
automated systems are similar to the actual inventory on hand.  
• Response time: The average time it takes between placing an order from a health facility 
to a higher facility (e.g district or provincial store) and when the order is received. 
Response time time is also referred to as order lead time or replenishment time. 
• Effective vaccine management (EVM) score: The EVM assessment is an approach used 
to assess the performance of the immunization supply chain at different levels from the 
national to the service delivery levels. The threshold for good performance is a score of 
80% WHO/UNICEF 201424. 
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• Cost of intervention 
• Adverse outcomes of the intervention 
• Acceptability of the intervention, as defined by the authors of the study. 
4.2.2. Search strategy 
We developed a comprehensive search strategy for peer-reviewed studies and grey literature. 
We searched the following databases between June and August 2018: PubMed and Embase. In 
addition, we searched the websites of the World Health Organisation (WHO), Global Alliance for 
Vaccine and Immunization (GAVI), PATH Vaccine Resources Library, United Nations Children’s 
Fund (UNICEF) and the International Clinical Trials Registry Platform (ICTRP) for trials. We 
screened the reference lists of all the included studies and related systematic reviews for other 
potentially eligible primary studies. We also performed a citation search for all studies that have 
cited included studies.  
4.2.3. Data collection and analysis 
Two authors (CJI and AJ) independently screened the titles and abstracts of the retrieved 
records to identify potentially eligible studies. The full texts of these potentially eligible studies 
were assessed using the pre-specified eligibility criteria. The two authors met to compare lists of 
included studies and resolved discrepancies by discussion and consensus. A data collection 
form was designed and used independently by two review authors (CJI and AJ) to extract data 
from the included studies. Disagreements were resolved through discussion, and a third author 
(CSW) arbitrated when the two authors failed to reach consensus. The following information 
was extracted from each included study; study setting (city and country), type of study, study 
participants, types and description of the intervention, comparator, and study outcomes.  
Two authors (CJI and AJ) independently assessed risk of bias in the included studies, using the 
criteria suggested by the Cochrane Effective Practice and Organisation of Care (EPOC) risk of 
bias tool 25. This tool is based on nine domains namely random sequence generation, allocation 
concealment, similar baseline outcome measurements, similar baseline characteristics, 
incomplete outcome data, adequate prevention of knowledge of the allocated interventions, 
protection against contamination, selective reporting and other potential sources bias. Of these 
nine domains, random sequence generation and allocation concealment were not used to 
assess risk of bias in the non-randomised studies. Each domain was judged as either low risk, 
high risk, or unclear risk. Each non-randomised study was judged to have low risk of bias if it 
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scored “low risk” for at least one of the following three domains: completeness of outcome data, 
similarity of baseline characteristics, and similarity of outcome characteristics. A non-
ransomised study was considered to have high risk of bias if it scored “high risk” for at least one 
of the three domains mentioned above. Differences in judgement were resolved by discussion 
between the authors and consensus, and there was no need for arbitration by a third author 
(CSW). Due to heterogeneity in the methods and outcome measures between the included 
studies, we could not conduct meta-analysis, hence we synthesized our data narratively.  
4.3. Results 
Our literature search yielded 5,462 records, out of which 5,459 were found through database 
searching and three through other sources. We excluded 5,455 clearly irrelevant records and 
assessed the full texts of the remaining seven articles for eligibility. Four studies met our 
inclusion criteria- three before-after studies and one randomised trial4,26–28. The reasons for 
excluding the three remaining studies 21,29,30 are provided in Table 1. Figure 1 is a flow diagram 
showing the process of study selection 31. 
One before-after study by Gilbert et al,  in 39 facilities  in two districts of Utar Pradesh in India, 
assessed the effects of a combination of three interventions4. The first intervention was the use 
of a standardized data collection process. This data collection process involved the use of 
papers to record the quantities of vaccines used in every immunization session. This information 
was then pooled together and captured into a digital software for monitoring of vaccine stock 
levels in real time using mobile phones, tablets, or computers. For the second intervention, the 
district level staff were assigned the responsibility of overseeing vaccine stock management 
activities across various facilities, to ensure that vaccines do not run out of stock or are not 
stocked in excess. The third intervention involved the training of the health workers at the 
facilities on the use of the both the standardised manual and digital tools. The interventions 
improved vaccine availability and reduced replenishment time. The impact was more in low-
performing facilities, where vaccine availability increased from 91% to 99%. The average 
replenishment time reduced from 5 to 2 days4. 
The second before-after study which was conducted in Benin and Mozambique by Prosser et al  
involved redesigning the supply chain system26. This redesign process involved the reduction of 
a four-level supply chain structure to a three-level structure. In a typical four-level system, 
supply of vaccines begins from the national store (level 1), through the provincial level (level 2) 
Stellenbosch University https://scholar.sun.ac.za
81 
 
 
and districts or subdistricts (level 3), to the health facilities (level 4) where they are administered 
to the target population. In both countries level 3 was removed and vaccines were delivered 
directly from level 2 to the healthcare facilities (37 in Benin and 111 in Mozambique). Additional 
transport systems were created, and logisticians were assigned to supervise these activities and 
ensure that vaccines were successfully delivered to the health facilities. The study observed a 
reduction in vaccine stock-outs from 79% to less than 1% in Mozambique, and an increase in 
the effective vaccine management score (EVM) from 52% to 65% in Benin. The study 
conducted in Mozambique measured the effect of the intervention on vaccine stock-outs rates 
and cost of implementing the intervention. In addition, the intervention was reported to be 17% 
more cost effective in Mozambique; but the cost per vaccine dose increased from US$0.009 to 
US$0.16 in Benin. 
The third before-after study by Ramnujapuram and Akkihal 27 was conducted in 29 primary 
healthcare centers in Karnataka in India27. This study assessed the use of “digital bulletin 
boards”27  by health facility managers who oversee the placing of new orders for vaccines. 
Vaccine stock levels, derived from real time data generated from primary healthcare facilities, 
were displayed on Television screens strategically positioned in managers’ offices or in places 
that are visible to them, to prompt them into acting. The study reported a steady improvement in 
vaccine availability up to 99%, though the baseline score was not mentioned. There was also a 
reduction in replenishment time from 14 to 5 days 27. 
The fourth study, a randomised trial by Pereira et al28, assessed the effect of using barcode 
scanning technology for vaccine record compared to the manual entry of vaccine records. The 
barcode method involved scanning the barcode on each vaccine vial such that all the 
information of the vaccine (such as lot number and expiry date) is captured in an electronic data 
recording system. The other approach involved manually entering all the vaccine information 
into a predesigned drop-down menu on the computer system 28. This study measured the 
completeness and accuracy of data entry. The study observed fewer errors when using barcode 
scanning, although the exact values were not reported 28.   
All included studies4,26–28 were judged to have high risk of bias since they scored high at least in 
one of the three domains, that is, completeness of outcome data, similarity of baseline 
characteristics, and similarity of outcome characteristics. The summary of our risk of bias 
assessment if shown in Table 2. 
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Table 1: List of excluded studies with reasons 
Study Study design  Reasons for exclusion 
Shieshia  201429  Before-after 
study  
The study assessed the effectiveness of an SMS 
and web–based reporting system used to report 
stock data using SMS through mobile phones. We 
excluded this study because its focus was on 
health products and did not specifically mention 
vaccines 
Kapuria 2014 30  Before-after 
study 
The study assessed implementation of vaccine 
logistic management system which enables the 
visibility of stock levels in real time coupled with 
strengthening of human resources capacity. We 
excluded this study because at the time of 
assessing the article, results of the study were not 
out yet 
 
Brown 2014 21 Modeling study This study assessed the effects of redesigning the 
vaccine supply chain. However, the authors 
conducted the study using computational modeling, 
a basis for exclusion in this review 
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Figure 1: Process of study selection for the scoping review on interventions for vaccine 
stock management 
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Table 2: Risk of bias assesment for included studies 
Domain Gilbert 2017 Prosser 2017  Ramanujapuram 
2014 
Pereira 2012 
Random sequence generation  
   
 
Allocation concealment  
   
 
Baseline outcome 
measurements similar 
 
 
 
 
Baseline characteristics 
similar 
  
 
 
Incomplete outcome data 
(attrition bias)     
Knowledge of the allocated 
interventions adequately 
prevented during the study 
    
Protection against 
contamination 
    
Selective reporting (reporting 
bias)     
Other bias 
    
 
Key: Low risk of bias;  High risk of bias;  Unclear risk of bias 
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4.4. Discussion 
The rise in occurrence of stock-outs suggests a need to improve vaccine stock management in 
countries, especially low- and middle-income countries15. We conducted a scoping review to 
evaluate the effects of interventions for improving vaccine stock management.  
Our comprehensive literature search identified a total of 5 462 records, out of which four which 
were found eligible for inclusion. Three of these studies were before-after studies conducted in 
low- and middle-income countries and one was a randomized trial conducted in a high-income 
country. The first study 4 showed that the use of a combination of interventions including use 
standard data collection instruments, digital tools, training of health care workers, and assigning 
specific roles to personnel, can increase vaccine availability and reduce replenishment time. 
The second study showed that redesigning a supply chain from a four-level system to a three-
level system can improve vaccine availability and reduce stock-outs 26. The redesigned process 
reduces the complexity of getting vaccines from the highest level in the supply chain to health 
facilities. This process resulted in an informed push system, in which vaccines are supplied from 
the higher levels of the supply chain to the health facilities, which is often informed by the level 
of consumption in these facilities. The findings from this study is consistent with another study 
conducted in Senegal, where introducing an informed push system reduced the rate of stock 
outs of contraceptives 32.  
The third study 27 showed that the use of screens to display abnormal stock levels to vaccine 
managers not only improves vaccine availability but can also reduce replenishment time. The 
fourth study showed that integrating barcode scanning on vaccine vials as opposed to manual 
method or drop-down menu to record vaccine inventory could reduce errors that occur when 
inventory data are captured.  
Most of the interventions described were effective in LIMICs 4,26,27 implying that they are likely be 
effective in similar settings, especially hard to reach areas.  
Three studies 4,27,28 in this review included a component of digital technology, to improve 
visibility of vaccine stock levels. Many countries have also adopted the use of digital systems to 
monitor vaccine levels, making them visible for managers to make informed decisions. 
Countries such as India, Mozambique, and Nigeria use these systems to improve vaccine 
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availability18.  South Africa for example, has developed the” Stock Visibility Solution” which is a 
mobile application designed to enable health facilities to monitor and capture stock levels daily. 
The information is stored in a cloud-based data management system and can send alerts when 
the stock is running low33. The use of digital technologies as interventions for stock 
management have advantages over manual methods and should be embraced by LMICs as 
they have the potential to strengthen health systems 34,35. Furthermore, data  from manual stock 
records are not usually efficient to support decision making, due to poor data quality, wrong 
estimates of vaccine consumption and late arrival of data at managerial levels 36. Manual 
reporting systems are also labour intensive and tend to overburden healthcare workers. This in 
turn affects the motivation of healthcare workers who may end up resenting the responsibilities 
of vaccine stock management because they often also have other duties including clinical duties 
9,36. When adequate data are not available, it affects the placing orders  and could lead to 
shortages35. In addition, findings from this review have underscored the importance of assigning 
a specific person at health facility level to manage vaccine stock, as highlighted in the studies by 
Gilbert et al 4 and Prosser et al 26 . 
Current evidence shows that the use of digital solutions are effective for solving public health 
problems, but the ones that target the vaccine supply chain are still scarce 36,37. To the best of 
our knowledge, this study is the first to assess the effects of interventions for vaccine stock 
management in health facilities where vaccines are administered.  
One of the limitations to this study is that most studies included in this review had high risk of 
bias mostly due to how they were designed and conducted. Also, the related outcomes in all 
studies were measured differently; there were no consistent methods for measuring outcomes 
such as stock-out rates and vaccine availability.  Thirdly, our study focused only on interventions 
for vaccine stock management, so we had to exclude studies that reported interventions for 
other health commodities which could be very useful for vaccine stock management.   
4.5. Conclusion 
Interventions such as the use of digital information systems (e.g., use of mobile devices, display 
screens and barcode scanning of vaccines for recording); training of workers; assigning specific 
roles to specific personnel and redesign of the supply chain, have the potential to improve 
vaccine stock management which eventually can increase vaccine availability. However, well 
designed studies are urgently required to increase the certainty of the current evidence base. 
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5.0. Abstract 
Introduction: The use of mobile and wireless digital technologies - mobile health (mhealth)- is 
increasingly been adopted in low- and middle-income countries (LMICs) to improve data 
visibility, improve decision-making, and consequently help ensure availability of health 
commodities in health facilities. In a bid to improve availability of medicines in primary health 
care facilities, the South African department of Health launched the Stock Visibility Solution 
(SVS), a mobile application developed for the purpose of capturing and monitoring stock levels 
of medicines including vaccines using mobile phones. The stock levels of medicines in facilities 
are usually uploaded to the central stock management system so that managers can act 
promptly to address stock-out situations. Pilot studies show that the SVS has the potential to 
reduce stock-outs from occurring.This study aimed to explore the perceptions and experiences 
of the SVS system amongst healthcare workers (HCWs) who are involved with managing stock 
levels of medicines in primary health care facilities in the Eastern Cape Province. This will help 
identify potential barriers and facilitators to implementation of the system and contribute to the 
development of strategies to improve its efficiency and effectiveness.  
Methods: A qualitative research design was employed, including semi-structured interviews 
with 64 HCWs working in primary health care facilities in the OR Tambo district, Eastern Cape 
Province in South Africa. Data was transcribed verbatim and analysed using thematic analysis.  
Results: Most HCWs understood the SVS as a system for reporting stock levels to managers 
and conveyed commitment to ensuring the system works. However, they highlighted a number 
of factors that demotivated efficient usage of the system: inadequate training, staff shortages 
and high staff turnover, lack of responses from the managers, the extra workload that comes 
with the system, amongst others. HCWs made various suggestions for how the system might be 
improved, most pertinently the need for more pharmacists and pharmacy assistants and for 
these cadres to be primarily in-charge of stock management and the use of the SVS.  
Conclusion: While HCWs are committed to addressing vaccine stock-outs, they face various 
barriers to an effective and efficient implementation of the SVS system. We make various 
recommendations for how these barriers might be addressed.  
Keywords: Stock visibility solution, supply chain, mhealth, digital health, mhealth, South Africa 
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5.1. Introduction 
The use of mobile and wireless digital devices to improve access to healthcare information 
(mhealth), is increasingly been adopted in low and middle-income countries (LMICs). 1,2These 
devices are being used to improve data visibility, enhance decision-making, and consequently 
help ensure availability of medicines in health facilities  3,4. The use of these mobile devices has 
the potential to tackle the challenges of stock-outs of vaccines and other health commodities in 
health settings. 1,2, especially in rural and resource-constrained areas 2.  
Vaccine stock-outs at primary healthcare facilities is one of the challenges facing the 
immunisation programme the health of the people of South Africa.5,6 Vaccine stock-outs and 
child deaths due to vaccine-preventable diseases are common in rural communities which are 
sometimes hard to reach.7 South Africa has made significant progress with the introduction and 
self-financing of new and underutilised vaccines. However, there have been reports that point to 
shortages of vaccines in many parts of the country8,9. In a bid to reduce the rate of stock of 
stock-outs of medicines, the department of health in South Africa developed the ‘stock visibility 
solution’ (SVS),  the South African department of health, launched a mobile application, the 
stock visibility system (SVS) for monitoring the availability of medicines in primary health 
facilities level.10–12 The SVS is designed to capture vaccine stocks through mobile phones.13 At 
the health facilities, the health worker in charge of stock management by reporting vaccine stock 
levels and other medicines to managers at district, provincial, and national levels. Stock 
reporting is expected to be done weekly by the staff in charge. During this time, the quantity of 
each stock item is counted, updated on the device and sent. The data is automatically uploaded 
to an online stock management system, whereby all managers can access the stock-levels of all 
the facilities in real-time. This central stock management system can detect stock-outs reported 
at the facilities, including details of the item and duration of stock-out. Warning signals are then 
sent to the managers prompting them to respond. 
In most cases, it is sub-district managers or other persons who are responsible for overseeing 
facilities within their region that respond. 10,13  When the managers receive the reports, they are 
meant to call facilities with low stock levels to confirm whether the item has been ordered from 
the depot. The manager can also attempt to source the item from other facilities where it is in 
stock. This stock redistribution helps to ensure that medicines are always available in the 
facilities and patients are not turned away due to stock-outs.  
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Pilot studies conducted in Kwazulu-Natal and Limpopo 14 provinces in the country showed that 
the SVS is capable of reducing stock-outs of medicines in primary health care settings 15. 
However, it is known that the success of a technological intervention such as the SVS will be 
impacted by the human element 10, including the staff at the facilities as well as the managers. 
The aim of this study was therefore to explore the perceptions and experiences of the SVS 
system amongst healthcare workers (HCWs) who are involved with managing stock levels of 
medicines in primary health care facilities in the Eastern Cape Province. This will help identify 
potential barriers and facilitators to implementation of the system and contribute to the 
development of strategies to improve its efficiency and effectiveness. 
5.2. Methods 
5.2.1. Study setting: 
Our study was conducted in the OR Tambo district in the Eastern Cape Province of South 
Africa. The OR Tambo district is the largest district in the Province with a population of 
1,382,399, which is 20% of the population of Eastern Cape Province. 16. It is a rural district 
comprising of four sub-districts- Nyandeni, KSD, Mthlontlo and Quakeni. The district was 
chosen as one of the National Health Insurance (NHI) pilot districts in South Africa, where 
various initiatives have been implemented to improve the quality of care. Some of these 
initiatives include the e-health strategy, supply chain management reforms, amongst others. 
The OR Tambo district also has high neonatal and child mortality, coupled with a high burden of 
HIV/AIDS and TB epidemic.   
5.2.2. Research design:  
We employed a qualitative research design, including semi-structured and in-depth interviews 
with HCWs in primary health care facilities across the four sub-districts of the OR Tambo 
district. This study forms part of a broader, quantitative study which is assessing the occurrence 
of vaccine stock-outs and vaccine stock management status of the health facilities within the OR 
Tambo district.  
5.2.3. Sampling and recruitment 
We employed a purposive sampling approach. For the broader, quantitative study, we visited 
facilities across the four sub-districts to capture data related to vaccine stock management. 
While visiting the facilities, we used the opportunity to conduct interviews with HCWs who are 
involved with capturing, monitoring and reporting stock levels of medicines. These HCWs were 
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pharmacists, pharmacy assistants and nurses. On the days we visited the health facilities, most 
of the people we approached were willing and happy to participate in the study despite their 
busy schedules.  
5.2.4. Data collection and management 
Individual interviews were conducted with participants between 25th February to 15th March 
2019. The interviews were based on a semi-structured interview guide which explored the 
following topics: knowledge of the SVS,  the impact of SVS on the occurrence of vaccine stock-
outs challenges faced by the HCWs using SVS and the HCWs’recommendations to the 
challenges. (See Appendix 1). The guide was flexible to ensure that participants could express 
what was important to them, and so learnings from previous interviews could be clarified and 
probed further in subsequent interviews. 
Before each interview, we explained to the participants the purpose of the study, sought for their 
consent and assured them of confidentiality. With the permission of participants, each session 
was recorded using a digital recorder. Also, notes of both verbal and non-verbal responses were 
taken during the interviews. Interviews were conducted at a convenient place chosen by each 
respondent. For example, interviews were conducted in the medicines storeroom or their 
offices. All interviews were conducted in English language and lasted between 30 and 60 
minutes. All interviews went smoothly, and only one participant pulled out in the middle of the 
interview for health reasons.  
At the end of the interviews, the recorded sessions were transcribed verbatim and saved in a 
passworded computer, in a file bearing the date the interview was conducted, the place where it 
was conducted, and the questions the interview addressed. Field assistants were employed to 
assist with the transcribing. However, each transcribed interview was verified by the principal 
investigator (CJI) to check for accuracy. 
5.2.5. Analytic process 
The transcribed data was analysed using thematic analysis.17 Thematic analysis is a useful 
method for identifying and describing recurring patterns that are present in data 17. Three 
authors (CJI, LM and SC) participated in the analysis. The analysis of these interviews began 
before data collection. We had meetings to deliberate and agreed on the analytic method to use 
based on the data that will be collected. Notes were made during the interviews and summaries 
were written after each interview to guide us through the analytical process. We shared the 
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transcripts amongst ourselves for independent coding and then met to agree on common codes 
and emerging themes. During this process, each author read the transcripts for adequate 
immersion in the data and notes were taken. We then developed themes which were used to 
code the data. We tested some of the identified themes against the interviews to be sure the 
information was well captured, bearing in mind the aims and objectives of the study. 
5.2.6. Ethical consideration  
Ethics approval was obtained from the Health Research Ethics Committee, Stellenbosch 
University (S18/08/154), the provincial department of health (EC_201810_009) and the OR 
Tambo district. All participants were assured of anonymity during the interviews. A consent form 
was provided to each interviewee before the onset of the interview. In the consent form, it was 
clearly stated that the interview would be recorded, and the discussion with the participants will 
be kept confidential. The participants were also informed verbally about how their confidentiality 
will be kept and that they are free to withdraw from the interview at any time. The data collected 
was kept safe and protected. Also, identifiers were removed from transcripts, and sound files 
were destroyed after the interviews were transcribed.  
 
5.3. Results  
A total of 64 participants were interviewed, from all the sub-districts within the OR Tambo 
district; 23 from Nyandeni 21 from KSD, 13 from Mthlontlo and seven from Quakeni. Each 
participant represented each of the 64 facilities. Table 1 below contains a list of respondents. 
Summary of themes generated from study 
Six main themes were derived from the data namely; knowledge of the purpose and functioning 
of the SVS system; frustration about the ineffectiveness of the SVS system; challenges 
encountered when using the SVS, (with its sub-themes), novel alternatives to the SVS system. 
Finally, a theme on recommendations made by the HCWS, for addressing identified challenges. 
The sub-themes that emerged from the challenges encountered by the HCWs include staff 
shortages and high staff turnover, inadequate training of HCWs, lack of response from the 
managers, increased workload, SVS reporting being time consuming, the inability of HCWs to 
meet up with sending reports. The major themes are written in bold, while minor themes are 
italicised in bold. Each of the themes is described below.  
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Table 1: Profile of respondents  
Sub-district 
Pharmacist Pharmacy 
assistant Vaccinator 
Facility 
manager 
King Sabata 
Dalindyebo  1 6 12 2 
Nyandeni 0 9 8 6 
Quakeni 0 4 1 2 
Mthlontlo 1 5 4 3 
All facilities 2 24 25 13 
 
5.3.1. Widespread knowledge of the purpose and functioning of the SVS 
system  
Most of the HCWs we spoke to conveyed considerable knowledge about the SVS, including its 
purpose and how it functions. Most participants described the SVS as a tool used for reporting 
the stock levels of vaccines and other medicines. Some even highlighted details the categories 
of medicines that are reported using the SVS, namely; vaccines, antiretrovirals, anti-tuberculosis 
(TB) drugs, and other tracer medicines: 
“with I SVS ke, we’ve got a phone here to where we were being asked about the TB drugs the 
vaccines, ARV, TB, the vaccines back since, we… we.., with the I SVS  we have to balance first 
the Medication and before you sent to you balance first in the medications and you… you send 
according to the balance of the bin cards yes and we do it on Tuesdays,  if not done on Tuesday 
then early on”(HF5). 
Many of the HCWs we spoke to also knew that the SVS helps to monitor stock availability and 
expiry dates of medicines, in addition to using the SVS to report medications:  
“ ..with vaccines we are able to check how many do we have at the moment, which one is about 
to expire and trying to get finished so if they’re short we are able to place a special order, so it 
reminds us if we haven’t placed an order it will say place an order for that because its running 
short” (HF1). 
They also described the SVS as a system that enables them to redistribute stock levels as well 
as a reminder for when stock levels are running low:  
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“Yes, definitely maybe there is somebody who is looking at the stock levels but the way I 
understood it is that we will share this stock” (HF35). 
“I thought that with SVS, those facilities who have enough stock or access will transfer to us” 
(HF11). 
 “so if they’re short we are able to place a special order, so it reminds us if we haven’t placed an 
order it will say place an order for that because its running short” (HF18). 
5.3.2. Frustration about the ineffectiveness of the SVS system 
We asked participants directly whether they felt the SVS had been an effective system in 
reducing stock-outs since it was introduced. Here, the overwhelming majority of the HCWs we 
spoke to felt the system had been ineffective. The widespread perception was that stock-levels 
had remained more or less the same since its introduction:  
“there is no difference, without this SVS and with SVS, no difference. I am saying so because 
we were having the problem with the immunisations before and even now we still have the 
same problem so no difference, so you we just like, we just send the stock numbers weekly, but 
we don't know what is happening” (HF46). 
Another participant expressed similar sentiments:  
 “It is not helping at all, we are suffering my dear, we are suffering here at the communities, 
maybe SVS is working in the suburbs, but here it is not working at all, in our areas, it is not 
working” (HF28). 
Some of the participants exhibited uncertainties, whether it has an impact or not: 
 “I cannot say if it is decreasing or increasing,”.  the  point is that, let's see what I've just talked to 
you that when you are in the dispensary, and you always see that something's out of stock, you 
think of it even before SVS and  you make a way of getting that drug” but then SVS has helped 
us a lot because now we always have to update (HF17).…” 
“otherwise, it is a reliable model; it' is fine, but I do not know as to we are the ones who are 
failing as nurses to share the stock amongst ourselves (HF54)..” 
The ineffectiveness of the system appears to be a source of considerable frustration for many of 
the participants we spoke. However, we were indeed struck by the level of commitment many of 
the staff appear to have, and their wish to ensure that vaccines are available.  
Stellenbosch University https://scholar.sun.ac.za
101 
 
 
“it is very bad to always not have when the client comes to not have this drug” (HF5). 
“..because it is not nice to tell the patient we don't have that go and ask somewhere..”(H18). 
“……. that is not for the patient, it is for me to make sure that the treatment we have but at least” 
(HF54). 
One participant recounted that they had to travel to other facilities to pick up vaccines. Another 
said that if she had to refer them to other facilities, she would ask the patients to return to the 
clinics to show proof that they had received the vaccines.  
Ultimately, the ineffectiveness of the system was perceived by some of the HCWs as 
demotivating, as expressed by this participant:  
“People are not motivated to report because we do not see the results” (HF25). 
5.3.3. Challenges to effective SVS implementation 
 
Lack of training on the use of the SVS and adaptation  
When the participants were asked if they had received any formal training on how to use the 
SVS device, most of them expressed that they had not been well trained. Knowledge was 
mostly passed down to them from their operational managers. In some cases, they were taught 
by their predecessors or colleagues. Many of them did not find this style of training useful, and 
hence, adaptation to the tool was a bit challenging: 
“Noo, only our OM (operational manager), she was trained. Yes, she was trained, and she came 
to train us” (HF16). 
“so, another one just phones you there and ask, hey how is the SVS thing going, ok. You see. 
You just go to the phone. You tick what and you click there then you do you your stock, and 
then you do what… so you see, that is not a training?” (HF60).  
5.3.4. Staff shortages and high staff turnover 
Also, there is understandably, a frequent migration of health workers in this region. That is, the 
health workers, especially the pharmacy assistants are not stable. The next person who comes 
after may not be able to operate the system.  
“our challenges are adapting. At times we are having a new staff so like I say now the one who 
was doing ilanto I medication she has just left for the study leave so I SVS is easy when you 
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know it but if you do not know it you feel like it is a difficult thing but when you are used to it is 
not that difficult.  You must be used to it” (HF35). 
5.3.5. Lack of responses from the managers 
Most participants recounted how lack of response from the managers is a huge challenge to the 
implementation of the SVS. They try to meet up with their reporting hoping that their managers 
will respond to the stock-out situations:  
“I really don't know because you are the first person who is asking me that question. I thought 
our pharmacist would be active enough to phone and check do you have enough of this in this 
because maybe another clinic has got so much, so that is what I was expecting” (HF44).  
“We just send the stock numbers weekly, but we do not know what is happening” (HF38). 
 
5.3.6. SVS contributing to heavy workload amongst the HCWs 
Firstly, most of the participants felt that the SVS poses as an extra burden for them, especially 
as there are a lot of medicines on the system to be reported weekly:   
“So, there are so many programs and it does make it difficult even now I’m alone so you see” 
(HF10). 
“Ok, Uhm, we do not only put immunisations ones only, there are other medicines from this, like 
TB medicines, everything in here, so it is too much, sooo… yaa, before it was only 
immunisations, ARVs, TB medicine soo…but now everything. So, it was fine when it was only 
immunisations, ARVs, and TB” (HF19). 
5.3.7. Reporting with the SVS is time-consuming  
Secondly, the participants felt that sending of reports is time-consuming. They spend much time 
capturing each item and sometimes stay beyond work hours in order to meet up with the days 
set for reporting weekly: 
 “it’s time, we don’t have time” (HF34). 
 “yah so I have to stay back at half past 4 and do it and complete it” (HF37). 
“so we've got a lot of work , we are few at the clinic so at times I do stay here when others knock 
off at half-past 4 and do the SVS, yes because of I shortage of staff ” (HF28). 
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5.3.8. Failure to send their reports  
Furthermore, due to their busy schedules, they sometimes fail or delay in sending their reports.  
 “But sometimes we do not enter the medicines that we are supposed to enter, because we will 
be busy. At times we do not have time to do this really well, we need someone on our service” 
(HF35). 
 “yah we have to order and sometimes our orders go late because we are busy, and when you 
order you do not need one day ” (HF62). 
5.3.9. Novel alternatives to the SVS system?  
As described earlier, the HCWs conveyed a high level of commitment to ensuring that vaccines 
are available for patients. This was revealed further by the descriptions various participants 
gave about the strategies they developed to facilitate sharing of vaccines among themselves. 
One of these strategies was the creation of online groups on ‘WhatsApp’. On the ‘Whatsapp 
groups, when one facility needs an item, the HCW in charge of that facility creates a post 
requesting if another facility could assist. Since other facilities have access to this group, 
whoever is willing to share, responds to the request. They also use their mobile phones to call 
neighbouring facilities and, in some cases, use their cars to pick up these items from other 
facilities. Driving to borrow vaccines from other facilities, asides being daunting also has 
financial implications: 
“yes, my dear, even with the WhatsApp thing, we are using our own data to rotate the 
medication, there is a group here, pharmaceutical group, but it’s not helping us…we use our 
own data, but somebody there is using official data, if there is an official data, I’m sure there is. 
Because even the cell phone is official, but here we are using our own data” (HF10). 
However, many participants expressed displeasure in using their personal resources for health 
service delivery, and felt that these novel strategies require more official support: 
“So, it’s like you have to do this using your own transport and what are they going to say, they 
are going to say, we do not replace for the transport(HF15). 
5.3.10. Recommendations for addressing identified challenges  
Participants provided two main suggestions for how the challenges they identified might be 
addressed. Firstly, most participants suggested that there should be pharmacists or pharmacy 
assistant in each facility who will be in charge of managing vaccines and of course, other 
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medicines in general. They felt that having a dedicated staff for these purposes will enable other 
staff like the nurses to focus their attention on their primary duties.  
 “They must help with a Pharmacy assistant; we are nurses not pharmacy assistants” (HF5). 
“there should be pharmacist., to do all the work for ‘I medication’(the medications)” (HF8). 
 
“So, the main issue is getting someone if these, if all the medicines will remain on the device, 
then they must get somebody that will manage” (HF15). 
 
“so it helps a lot but if we can have a pharmacist is will real help a lot. because now you are 
doing this and then this one of the sisters will come and say we do not have this we have to stop 
doing your admin and then to concentrate on this and phone all these clinics to find out do you 
have this” (HF18). 
 “mm, yes, Pharmacy assistant, it would be nice,  Because we have to, we see the patient and 
then you have dispense for them And then I have to do my admin and  I have to order the 
medication, there are things, like this stuff and HR things that I have to attend the meetings, I 
can say to my manager, no I have to do pharmacy things when she when there's a meeting. So, 
“I have to be at all places, you understand. So, if at least we can have a pharmacist I will be 
pleased” (HF5). 
 
Secondly, many participants suggested that their managers at the sub-district and even district 
levels should endeavour and respond promptly and offer support to them, especially regarding 
the redistribution of stocks between facilities. Even if there are no vaccines available, they still 
would like to receive feedback from the managers to show that they are aware of the situations 
in the facilities. 
“I think we have to involve all facilities in sub-district and then the district, we have to support 
each other, we are not being supported by our superiors” (HF16).  
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“If our supervisors can be involved at least it can help, move a little faster but it is not working, 
it's slow” (HF18). 
 
“what I think can be done is for whoever is receiving the information can check as to who is out 
of stock not necessarily on weekly basis if she checks once because at the end we are also 
waiting for our stocks from the depot as I said we are ordering every month because of 
unreliability of our storage and electricity, ; yes, because if you phone us, and we are supposed 
to receive stock today, and we have the circle, the SVS circle yesterday and he looks today and 
see that we don't have for example BCG and other meds and then he sends to the health 
centres, or the other clinics that are close to us, if they have let's say 50, at least 10 for a week 
then it is shared amongst us if he phones and we say we have not received stock then a facility 
can send us 10 and when we receive the 50 then we send it back to the clinic” (HF25). 
Thirdly, the HCWs suggested that the bin cards be phased out.  In these facilities, the bin cards 
have been used for a long time for recording stock levels of vaccines, and also other information 
like name of the vaccine, quantity, vial size, expiry dates and others. The bin cards are meant to 
help them monitor their stock levels in the facilities. While the information on the bin cards which 
is supposed to match with the physical quantities are also recorded on the SVS and sent to the 
managers, who can see the stock levels in the facilities. The HCWs would prefer to work only 
with the electronic device and not both. Updating both the stock cards, and the SVS is really 
much work to do, considering that they have to attend to their patients: 
“I would be happy if they would do away with the bin cards” (HF10) 
 
Lastly, they would also want to have access to the data on stock levels of other facilities so that 
they can know which facility to call when they are in need. Although this is meant to be done by 
the managers themselves.  
“If they can give everyone access to other facilities’ information... If it can also show the stock 
visibility at the depot” (HF10). 
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5.4. Discussion 
In this study, we have explored how HCWs involved with stock management in primary health 
care facilities in the OR Tambo district perceive and experience the use of the SVS for 
monitoring and reporting vaccine stock levels.  
The HCWs are extremely knowledgeable about the purpose of SVS and how it works. They 
understand that it is meant to assists them in monitoring the stock levels of vaccines in the 
facilities, prompts them when stock is about to expire and mostly how it is used for reporting 
stock levels to the managers. They also do acknowledge that the system was created to help 
them reduce the level of stock-outs that occur in the facilities. Since they are meant to report 
every week, most of the participants reported that they hardly missed the chance to submit their 
reports. Also, they are extremely motivated to reduce stock-outs and its impact on the patients.  
Despite the commitment to consistent reporting using the SVS, they are concerned and 
frustrated that the SVS system is currently ineffective. They identified all sorts of challenges 
contributing to its effectiveness. Firstly, the lack of response from the managers. Ideally, when 
the managers receive the reports, they are expected to respond to the facilities with low stocks 
of vaccines, by assisting in redistributing vaccines between facilities. The reasons for the lack of 
response from the managers is not clear in this study as we could not interview them. However, 
this lack of response from the managers may be due to failure on their part to monitor stock 
levels of medicines in the facilities assigned to them.  Also, one may want to ask questions 
around the exact format in which these reports are received on the managers’ side. In other 
words, how do these managers make sense of these reports received from the facilities?. Are 
they properly trained?. Also, do they face similar challenges as the staff in the facilities where 
they may be overburdened and may not be able to respond promptly?.  Getting answers to 
these questions may assist in understanding the reasons for the lack of response from them. 
Furthermore, the lack of support from managers is a factor responsible for low motivation 
amongst health workers in developing countries. This was shown in a systematic review where 
the majority of studies (85%) reported that lack of support or proper supervisory roles from the 
superiors de-motivated the health workers 18. Also, the availability of health commodities has 
been identified in the same review 18 and another study 19, as one of the motivating factors for 
health workers, while the lack thereof, can be a strong demotivating factor 18. The recurring 
stock-outs of vaccines probably explains the frustration felt by the participants in this study.  
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Another demotivating factor identified from this study is that the health workers felt that the SVS 
is an extra burden on them, considering that they have other primary health care services to 
deliver. Mounting workload, in rural facilities, is a factor responsible for low motivation among 
health workers.19 The extra burden that is being experienced from using the SVS, the delay in 
receiving responses from the managers, delay in receiving orders from the depot, and the 
urgent need to send reports of stock levels of vaccines and other medicines every week, could 
explain the frustration and anxiety among these health care workers.  
The HCWS are also developing novel, ground-up alternative strategies for managing and 
reducing stock-outs. They use their phones to make calls; they formed ‘WhatsApp’ groups 
where they share items and sometimes use their vehicles to fetch vaccines from neighbouring 
facilities. Situations, where health workers use their personal resources to assist in health care 
delivery, are common in developing countries and have been reported in other studies.20,21 
Some studies have also shown that health workers use online communities like WhatsApp’ 
‘Facebook’ to respond to stock-outs and to share knowledge among themselves.2,20 The use of 
alternative strategies holds great potential for the development of interventions which are 
contextually appropriate and acceptable to those who are tasked with managing stocks. 
However, if these are to be harnessed, they need support.  
5.5. Recommendations 
Staff shortages as reported by the participants in this study have been shown to be among the 
challenges of the health system the OR Tambo district16 and other low and middle-income 
settings, especially the rural areas.2,19 If this problem is not tackled, the realisation of the full 
impact of interventions like the SVS may be threatened.19 It is, therefore, an important for 
policymakers to seek ways of addressing staff shortages at the health facilities and the sub-
district levels. Health workers need to have the right emotions towards their work as low 
motivation has an undesirable impact on the performance of individual health workers, facilities 
and the entire health system. It could also contribute to the migration of health workers from 
rural areas to the cities.19 
Finally, if the managers are too busy to look at the reports sent from the facilities, then there 
may be a need to adopt specific strategies to prompt them into responding on time. For 
example, a study conducted in India reported that digital screens were mounted at strategic 
positions on the offices of the managers22. These screens were meant to project only abnormal 
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levels of medicines such that the managers can quickly identify facilities who need help and 
assist them without necessarily checking their systems.  
5.6. Study limitation 
Not being able to interview the managers at the sub-district and district levels was a limitation to 
this study. Their voices would have provided a balanced view of the study.  
5.7. Conclusion 
The SVS has the potential to minimise the occurrence of stock-outs of vaccines and other 
health commodities in the health facilities. However, it may contribute to the extra workload 
being experienced by health workers in rural areas, coupled with the current shortage of staff.  
There is a strong commitment on the side of health workers, ensuring that vaccines and other 
health commodities are continuously available for their clients. However, their zeal is reduced by 
the unavailability of health commodities at the facilities, delay in deliveries from the depot, and 
the slow response from the managers. There is a need for policymakers to seek ways of 
addressing stock-outs, addressing issues around the health workforce and providing adequate 
training for the health workers.  
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CHAPTER SIX 
Discussion and conclusion 
6.1. Introduction 
The availability of health commodities at the point of services is a fundamental component of the 
health system and also crucial for achieving universal health coverage (UHC).1,2 Stock-outs of 
essential health commodities such as vaccines is still a challenge, particularly in resource-
constrained settings. Vaccine stock management is a critical aspect of the supply chain that 
ensures that vaccines are always available at point of care.3–5 Stock-outs of vaccines in health 
facilities have been linked to poor stock management. 
This study aimed to evaluate the management and availability of vaccines in primary health care 
facilities in OR Tambo district, Eastern Cape Province. As part of the background to the study, a 
systematic review of both published and grey literature was conducted to provide evidence on 
the magnitude of vaccine stock-outs in the WHO African region. The evidence gathered from 
this review captured occurrence of vaccine stock-outs at different levels of the supply chain; the 
national, district and the health facilities and a link between the stock-outs that occur at the 
higher levels and those of the lowest levels. The causative factors of vaccine stock-outs at 
health facilities, which is the primary interest of this study were identified from the review. Poor 
vaccine stock management was found to be one of the major causative factors for vaccine 
stock-outs in health facilities, especially in low-and-middle-income countries.  
This chapter provides an overview of the key findings and reflections on each objective of this 
study. Also, this chapter will describe the key findings, contribution to knowledge, implications 
for policy, study limitations, conclusions and future research. 
 
6.2. Key findings 
6.2.1. Vaccine stock-outs in Africa  
This study revealed that significant stock-outs still occur at national and district levels in 
countries within the WHO African region, with a direct impact on the delivery of immunisation 
services. The vaccines most affected are BCG and oral polio vaccine. 
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When stock-outs occur at higher levels in the supply chain, there is a high chance that the lower 
levels will be affected. Findings from this study also highlighted the considerable gap that exists 
in the reports of stock-outs at the health facility level, the most critical level in the supply chain 
as it has a direct impact on service delivery and ultimately on the population served. The study 
also revealed that many countries do not have systems for routine monitoring of vaccine stock-
outs. South Africa is one of the few countries that seem to have a routine survey for stock-outs 
at the service delivery levels ongoing since 2013. Although the method used for the survey 
strongly underestimates the level of stock-outs occurring in the facilities. This routine survey 
revealed that stock-out rates could vary significantly between regions in a country, which is quite 
an important finding for health managers and policymakers.  
Evidence from the literature review reveals that vaccine stock-outs in health facilities are mostly 
caused by poor stock management. Other factors that the literature review revealed include the 
introduction of new vaccines, lack of skilled personnel, disease outbreaks and an inadequate 
supply chain structure. Some of these factors were identified in the study in the Eastern Cape, 
such as lack of skilled personnel. The literature review findings were supported by the study 
conducted in the Eastern Cape, where there was poor vaccine stock management. There was 
also a lack of skilled personnel for vaccine stock management in the Eastern Cape. The nurses 
were mostly in charge of managing vaccine stocks and lacked the technical knowledge, 
especially regarding quantification of needs which is necessary for forecasting and ordering. 
This further complicated the situation where the supply chain structure is a pull system; the 
facilities are expected to place orders based on their needs. 
 
6.2.2. Vaccine stock-outs and stock management in rural South Africa 
Our study, which assessed the occurrence of vaccine stock-outs, in OR Tambo district, showed 
that significant vaccine stock-outs occurred. Almost 80% of facilities reported a stock-out of at 
least one vaccine on the day of the visit.  This is way higher than many countries and higher 
than the figures reported by the Stop Stock-out Project (SSP) in South Africa. This could mean 
that it is best to assess stock-outs with physical counts of items since other methods may 
underestimate the magnitude of the problem. Furthermore, vaccine stock-outs occurred 
regardless of the presence of pharmacy personnel; pharmacist or pharmacist’s assistants. With 
these high rates of stock-outs, the emphasis by the department of health on “Everyday is an 
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Immunisation Day”6 may not be achieved as some patients may be turned away due to lack of 
vaccines at the health facilities.   
The assessment of vaccine stock management practices in OR Tambo district showed that the 
stock-cards are not used according to guidelines and expectations. Stock cards are still in use in 
all facilities, but the HCWs are reluctant to fill these cards. Failure to use stock cards and record 
all vaccine transactions on the stock cards as required, meant that stock cards could not be 
used for other critical functions such as estimating consumption rates. Many studies have also 
revealed that HCWs hardly update the stock cards.7–9 It is therefore probably long overdue for 
the stock cards to be replaced with electronic stock management systems like the Px solution. 
The rapid global expansion of digital technology has emerged and provides an opportunity for 
mitigating the challenges of commodity distribution and stock-outs2. This might be an important 
opportunity for stock cards to be replaced by electronic stock management systems. An 
electronic management system should be able to perform all functions of the stock cards 
adequately. Where possible, a single system should be designed that can be used for stock 
management in the facilities and for reporting of stock levels to the managers at higher levels.  
Delays in the delivery of stock from the pharmaceutical depot also affected the supply of 
vaccines to the facilities. The lack of skilled personnel revealed in the study in the Eastern Cape 
corroborated the report from the literature review.  
 
6.2.3. Interventions for improving vaccine stock management 
Our study in the Eastern Cape motivated the need to conduct a scoping review to identify 
interventions that could be used to improve vaccine stock management and increase vaccine 
availability. Most studies identified were conducted in low-and middle-income countries, and 
most of the studies reported the use of digital devices, to improve the quality of vaccine records 
and stock visibility. These interventions led to an increase in vaccine availability, improvement in 
accuracy of records and reduction in response times. The use of digital tools to improve stock 
visibility is like the stock visibility solution (SVS) system, which is being used in our study 
setting. The first study included in the scoping review, which was conducted by Gilbert et al.10 
incorporated three interventions targeted at the recording process and on the personnel 
managing vaccines.10  The first intervention was the use of a standardised paper to capture 
stock utilisation which was then transferred into digital devices, such as mobile devices or 
computers(second intervention). The third intervention involved the use of dedicated personnel 
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at the district level to manage vaccine stocks. In the Eastern Cape, there are officials dedicated 
to receiving and acting on the reports from the SVS in the facilities.   
The second study in the scoping review described how the redesign of the supply chain led to 
the improvement in vaccine stock management. This redesign process involved a reduction in 
the number of supply chain levels from a four-tier system to a three-tier system.11 This system is 
most preferred as it has been shown that fewer levels in a supply chain improve vaccine 
availability through improved efficiency of the supply chain.11–17 Interestingly, the Eastern Cape 
supply chain system operates on a three-tier system, where supplies are received by provincial 
from the national depot and supplied directly to the health facilities. In the study by Prosser et 
al.11, apart from the redesign of the supply chain, in Benin for example, a person was dedicated 
at the district level to collect vaccines from the regional stores, conduct monthly visits to the 
facilities for three purposes; vaccine distribution, collection of cold boxes, and supportive 
supervision. This dedicated person was also involved in analysing the data that was generated 
by the facilities for planning distribution. Refresher training was also conducted for health 
workers at the facilities. The interventions improved vaccine availability and reduced response 
time. Conducting refresher training in the Eastern Cape or generally, may be vital in improving 
vaccine stock management in primary health care facilities.  
The third study in the scoping review describes the use of a digital tool, “bulletin board” to send 
the stock levels to the managers.18 The ‘bulletin board’ was mounted on strategic positions that 
are easily visible to the managers. It was designed to project abnormal events such as stock-
outs and excess stock to managers, thereby prompting them to take action. While the 
interventions described above have some similarities with the findings in the Eastern Cape 
province, this type of intervention was not identified in the OR Tambo study. The use of similar 
interventions may be useful in our study setting and beyond, where there is a lack of response 
from the managers. Figure 1 below shows a picture of the bulletin board and how it transmits 
information to the managers.  
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Figure 1: A typical Bulletin board that displays abnormal stock levels for the managers 
 Source: Ramanujapuram & Akkihal 18 
 
 
 
Figure 2: The events that are displayed to the managers by the ‘Bulletin board’  18 
 
6.2.4. The perceptions and experiences of HCWs with the SVS 
The study on the experiences with and perceptions of the Stock Visibility system (SVS) by 
health care workers in OR Tambo district, found that most HCWs understood the function of the 
SVS, as a system for reporting stock levels to managers. However, potential barriers to efficient 
use of this device were noted. These factors include lack of response from managers, which 
was highlighted by a lot of the participants. Hence, they resorted to the use of “WhatsApp” to 
redistribute items between facilities. Such factor in other settings may have prompted the 
recommendation by WHO, that stock notifications should be used in settings where there is a 
timely response to stock-outs notifications.2 Other potential barriers to the use of SVS in OR 
Tambo district include extra workload, staff shortages and occurrence of stock-outs despite the 
use of the SVS.  
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6.3. Contribution to knowledge 
This study contributes to the field of vaccinology, mainly supply chain management through the 
following ways: 
i. Information on the magnitude of vaccine stock-outs in primary health care facilities in OR 
Tambo District in the Eastern Cape.  
ii. The method used for assessing the stock-outs situation in the Eastern Cape province 
provided an actual situation as compared to other methods, such as the telephonic 
survey methods which most likely provides an underestimation of the occurrence of 
stock-outs in primary health care facilities. 
iii. Studies on the assessment of vaccine stock management practices in South Africa are 
very scarce. This study provided a comprehensive assessment of the vaccine stock 
management practices in the OR Tambo district of the Eastern Cape province, 
highlighting areas that require improvement which may be useful to the policymakers on 
EPI.  
iv. The scoping review highlights different approaches used by countries for stock 
management and reveals gaps for future research. For example, the scoping review 
revealed the need for well-designed studies that show the effectiveness of interventions 
to improve vaccine stock management.  
v. The systematic review on the occurrence of stock-outs revealed provided a 
comprehensive picture of the magnitude of stock-outs at the national, district and health 
facility level in the WHO African region.   
vi. The experiences of health care workers using the SVS, which revealed barriers to the 
efficiency of the system. This is a notable contribution to the body of knowledge, 
especially on the use of digital interventions to improve vaccine availability.  
6.4. Implications for policy 
Most primary health care facilities are operated by nurses. Therefore, the nurses need to be 
trained and retrained at intervals on the management of pharmaceuticals and specific training 
on management of vaccines and such training should include specific qualities and 
requirements of vaccines, forecasting, management of cold chain and wastage. In addition to 
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training, the managers should always supervise and support health workers who are involved in 
stock management, to ensure they follow standard guidelines for stock management and to 
respond when their reports indicate that they lack vaccines. Sub-district managers should 
conduct regular visits to facilities and take action on the challenges they find.  
There is a need to address human resources and pharmacy personnel issue and establish a 
standard if there is none in relation to the staffing of health facilities. It is also essential to review 
how the current situation fares in relation to such standard. If possible, more pharmacist’s 
assistants should be employed so that they can be dedicated entirely to management of 
pharmaceuticals, and the nurses can focus on their primary duties in the facilities. There is a 
need for supportive supervision for effective adoption of the SVS. There is also a need for the 
use of electronic stock management systems in primary health care facilities. Such systems 
should integrate both stock monitoring and recording, stock reporting and possibly, 
immunisation coverage.  
Policymakers should establish the minimum standard for health facilities and cold chain 
equipment they should have. Several facilities had limited cold chain capacity. Some facilities 
had other products like antiretrovirals, insulin, Rabies vaccine and some of the maternity drugs 
competing with vaccines for the minimal cold chain space. Policymakers should conduct a 
countrywide assessment of the cold chain and address this huge challenge for some facilities. 
Health care workers have no clue on how to manage vaccine wastage, and there are no reports 
available on wastages. It is vital that this area is addressed and a clear programme should be 
directed at assessing the level of wastages and cost implications of all pharmaceuticals in all 
health facilities.  
Finally, it is anticipated that the findings of this study will benefit policymakers as it provides 
crucial information for EPI programme on the current situation with vaccine stock availability and 
management in selected facilities in the Eastern Cape and on ways to improve vaccine stock 
management and to ensure availability of vaccines. The experiences of the HCWs on the use of 
SVS may help in further modifying the SVS as appropriate. Although the primary study is within 
the context of a rural district in the Eastern Cape Province of South Africa, it could serve as a 
guide for similar settings within South Africa and other countries. 
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6.5. Study limitations 
Our study was conducted in the OR Tambo District of the Eastern Cape. It may not be 
representative of the entire province but can give a snapshot of the situation in a resource-
constrained area. Secondly, the magnitude of stock-outs from the Eastern Cape may be an 
underestimation considering that data was missing from facilities where stock-cards were not 
available. Finally, we could not reach the managers who receive the report on stock levels from 
the health facilities. Hence the experiences described in the study were mainly from the HCWs. 
6.6. Conclusion  
Vaccine stock-outs is still a significant issue requiring urgent attention in the Eastern Cape 
Province of South Africa. They may have been caused by factors within the health facilities, 
such as poor vaccine stock management practices and factors outside the health facilities, such 
as delay in response time from the depot and lack of response from managers. This implies that 
poor vaccine stock management noted in the study facilities may be linked to a broader systems 
issue. There is a need for improvement in the areas highlighted in this study.  
 
6.7. Future research 
The following studies may be important to undertake in the future: 
i. Exploring the experiences of the managers who receive Stock Visibility System reports 
from the facilities  
ii. Studies looking at interventions that for improving communication between the vaccine 
supply stores and health facilities 
iii. A study to assess the vaccine cold chain in primary health care facilities in OR Tambo 
District  
iv. A study to assess the level of vaccine wastage and its cost implications in primary health 
care settings 
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List of Appendices 
 
Appendix 1: Search strategy for a systematic review of vaccine stock-outs in primary 
health care facilities in Africa, for both PubMed and Scopus  
  
  
  
  Query - terms / phrases entered This column shows terms /phrases covered by 
what is entered 
#5 Search #3 AND #4   
#4 Search "primary health care 
facilities" OR "Primary health care 
facility" OR "Primary health care 
clinic" OR "Primary health care 
clinics" OR "Health centers" OR 
"Health centre" OR "Health 
centres" 
"primary health care facilities"[All Fields] OR "Primary 
health care facility"[All Fields] OR "Primary health 
care clinic"[All Fields] OR "Primary health care 
clinics"[All Fields] OR "Health centers"[All Fields] OR 
"Health centre"[All Fields] OR "Health centres"[All 
Fields] 
#3 Search #1 OR #2   
#2 Search "Vaccine stockout" OR 
"Vaccine stock-out" "Vaccine 
unavailability" OR "Vaccine 
availability" OR "Vaccines 
stockout" OR "Vaccines stock-
out" OR "vaccines unavailability" 
OR "Vaccines availability" 
(("vaccines"[MeSH Terms] OR "vaccines"[All Fields] 
OR "vaccine"[All Fields]) AND stockout[All Fields]) 
OR (("vaccines"[MeSH Terms] OR "vaccines"[All 
Fields] OR "vaccine"[All Fields]) AND stock-out[All 
Fields]) AND "Vaccine unavailability"[All Fields] OR 
"Vaccine availability"[All Fields] OR 
(("vaccines"[MeSH Terms] OR "vaccines"[All Fields]) 
AND stockout[All Fields]) OR (("vaccines"[MeSH 
Terms] OR "vaccines"[All Fields]) AND stock-out[All 
Fields]) OR (("vaccines"[MeSH Terms] OR 
"vaccines"[All Fields]) AND unavailability[All Fields]) 
OR "Vaccines availability"[All Fields] 
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#1 Search "Vaccine stock 
management" OR "vaccine 
management" 
(("vaccines"[MeSH Terms] OR "vaccines"[All Fields] 
OR "vaccine"[All Fields]) AND stock[All Fields] AND 
("organization and administration"[MeSH Terms] OR 
("organization"[All Fields] AND "administration"[All 
Fields]) OR "organization and administration"[All 
Fields] OR "management"[All Fields] OR "disease 
management"[MeSH Terms] OR ("disease"[All Fields] 
AND "management"[All Fields]) OR "disease 
management"[All Fields])) OR "vaccine 
management"[All Fields] 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Stellenbosch University https://scholar.sun.ac.za
124 
 
 
Appendix 2: The questionnaire for assessing vaccine stock management in OR Tambo 
district 
Sub-District  Facility Name  Date and Time  
    
Position Respondent  Pharmacy Assistant  Vaccinator  Facility Manager Other  
 A: General system and overview 
No. Question Y  N Comments Elaborate 
1 Is this an ideal clinic?    
2 Cold Chain Manual/ Vaccine Stock Management 
Guide available (from National DoH) 
  Indicate if verified: Yes or No. 
3 Eastern Cape DoH - SOP for Pharmaceuticals, 
Available? 
  Indicate if verified: Yes or No. 
4 What type of cold chain equipment is used?   1. Domestic Refrigerator/s 
2. Vaccine Fridge/s:  
a. Upright Vaccine Fridges (minus 40)  
b. Chest like Vaccine fridge, Dometic. 
3. Other: glass door fridges, etc.  
5. Do you know temperature hold time of the fridge?    
6. Do you have adequate fridge capacity?    
 B : Assessment of stock management procedures 
7. How is Vaccine Stock Managed? 
a. Manual Stock cards 
b. Computerised System 
c. SVS 
d. Other 
   
8. What system/ form is used to order vaccines? 
a. Requisition form/book with carbon copy. 
b. Another form system  
Are records kept? 
   
9.  How often are vaccine normal orders placed. 
a. Monthly 
b. Every 2 months 
c. Weekly. 
   
10.  Are there delays in the delivery of stock?    
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11. If Yes – How long are these delays (commonly)? 
a. Delay by 1 week 
b. Delay by 2 to 3 weeks 
c. Delay by a month or more. 
   
12.  Are special emergency orders used?     
13. How soon are emergency orders received?  
Are they helpful? 
   
 Receiving stock: Is there a special record of 
orders received other than stock card? 
   
14. On stock arrival, Is there a standard procedure to 
check: Condition, Expiry date, VVM, etc.  
   
15. Are these recorded and such records kept? 
 If yes where? 
  Verify if Yes- where recorded. 
 Are you familiar with FIFO/ FEFO principle?    Verify in fridge 
 Is the FIFO/ FEFO principle applied?    
16.  Stock Cards: Observe to Verify this information. Only indicate yes when verified  
17. Is the expiry date recorded on received stock?    
18. Are batch numbers recorded on received stock?    
 Do you understand Maximum and Minimum 
levels? 
   
19. Are Minimum levels on stock cards?    
 Are Maximum levels on stock cards?    
18. Are they up to date/ filled regularly within 1 week?    
19. Is there a stock card for measles diluent?    
20. Do the measles doses match with diluent?    
 Reduction of Orders and  managing wastage 
19. Does the depot or the District Pharmacist reduce 
the quantities of orders placed? 
   
20. Which vaccines do they frequently reduce?    
21. Do you know the procedure to follow when 
vaccines are destroyed, expired? 
   
22. What is it? Explain  
23.  Any disposed expired/wasted vaccines in last yr?    
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24.  Are there records of disposed pharmaceuticals?    Verify if Yes- where recorded 
25. Do you know how to calculate vaccine wastage?    
26. Are you expected to report on wastage?    
 Stock Levels and stock out 
 Are you currently out of stock of any vaccines?    
 Which vaccines are out of stock? Mention    
 How long have you been out of stock of above?     
 In the last year were you out of stock of vaccine?    
 Which ones ?    
 How long in average were these out of stock? 
a. On and off for over the year. 
b.  Less than month. 
c. Over one moth 
  Elaborate 
 SVS system and Demonstration 
 Is your SVS system working, currently?    
 Has someone been trained on it in this facility?    
 Have you had challenges with it? If yes  what?    
 How often do you update and send data.    
 Has the SVS helped/ had a good impact in 
addressing shortages of vaccines. 
  Elaborate 
 What can be improved with the SVS?  
 Are there other challenges with SVS?    
 OBSERVATION: Fridge and Cooler Box 
 Vaccines and Contents neatly packed.    
 FEFO Applied?    
 Is the temp chart a true reflection of fridge temp?    
 Are there Frozen vaccines?    
 If Yes which ones are frozen?    
  Do vaccines touch back plate with ice? Or ice 
accumulated in the fridge? 
   
 Are there Expired Vaccines?    
 Which vaccines are expired?    
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 Are there opened vials of expired vaccines?    Indicating use of expired vaccines  
 Are there vaccines at VVM discard point?    
 Are vaccine doses and diluents equal or close?    
 Are vaccines in fridge door or vegetable drawer?    
Fridge Stock  
 Vaccine No. 
Doses 
Expiry Date Expired  Overstock Y/N  Comments 
 BCG      
 Measles      
 Measles 
Diluent 
     
 Rota      
 PCV      
 Hexavalent      
 Polio      
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Observation of stock cards 
 
Minimum= Y/N Maximum = Y/N Batch No.s  = Y/N Frequency use: Good= 4, Fair=3, Poor =2, V Bad=1 
 
  When received Useful record:  Good= 4, Fair=3, Poor =2, V Bad=1 
 Vaccine Stock Level  Date Last Filled Earliest Record Date Zero levels in  2 yrs. 
Include duration 
BCG     
Measles     
Rotavirus     
PCV     
Hexavalent     
Polio     
Notes 
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Appendix 3: Information sheet and consent form  
 
Information sheet 
Each participant will be given a chance to read study information sheet 
Thank you for agreeing to take part in this study. Before I begin, I would like to explain why we 
would like to talk to you. This study is to find out about vaccine stock management and 
adherence to set standard practices for vaccine stock management. The study also aims to 
establish the situation with the occurrence of vaccine shortages, what causes shortages as well 
as the impact of the Stock visibility solution (SVS) on vaccine stock outs.  We want to know 
whether the SVS tool that is being used makes a difference to ensuring vaccine availability. For 
the purposes of this interview, we would like to hear your views and experiences.   
We want you to fill the questionnaire that will be provided to the best of your knowledge. At 
intervals, we may also do some physical checks in the vaccine store. We also want to hear your 
personal views and experiences. If you feel uncomfortable about answering any of the 
questions, you do not have to answer them. We will also request to review records on stock 
management including stock cards, computer records, ordering forms and similar related 
records. This study is for the purposes of research only and aims to contribute new information 
that can help improve vaccine availability and reduce stock-outs. This interview session will take 
60 – 120 minutes including the physical checks.  
Do you have any questions before we start? If not, you can ask a question at any time while 
answering the questions and at the end. 
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Consent form for participants 
Please complete this form in ball-point pen so that your writing can be seen on the bottom copy 
                                                                                                                    
1. I confirm that I have read and understood the information sheet dated ………for the above 
study.  
 
2. I have had the opportunity to think about the study and to ask questions about taking part. I 
am happy that my questions and concerns have been addressed. 
 
3. I understand that my participation is voluntary and I am free to withdraw at any time, without 
giving any reason, without my medical care or legal rights being affected. 
 
4. I understand that this project has been reviewed and received ethics clearance by the 
Stellenbosch University of Ethics Committee  
5. I understand my personal details such as name, phone number and household will not be 
revealed to people outside the project.  I understand that the information I provide may be 
archived by the project. I understand that the information I provide may be used in 
publications, reports, web pages, and other research outputs in an anonymised form.  I 
understand that other researchers may have access to this data only in a securely 
anonymised form.  
 
6. I understand that if I have any concerns or complaints about the study, I can contact the 
Student’s supervisor (Prof Charles Wiysonge) or the Chairperson of Stellenbosch University 
Human Research Ethics committee (who is not directly involved in this project). 
7. I agree to answer the questions.   
 
Name of participant:  
Date: 
Signature: 
 
 
Name of Researcher:  
Date: 
Signature: 
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Appendix 4: Ethics approval from Stellenbosch University, Eastern Cape department of 
health and OR Tambo district respectively 
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Appendix 5: Search strategy for scoping review of interventions for vaccine stock 
management 
 
Database: Pubmed 
 
No Query 
#1 Search "Vaccine management" OR "Vaccine stock 
management" 
#2 Search "drug storage" AND (vaccine OR vaccines) 
#3 Search "vaccine stockout" OR "Vaccines stockout" 
#4 Search (vaccine OR vaccines) AND "supply chain 
management" 
#5 Search (vaccine OR vaccines) AND "supply and distribution" 
#6 Search #1 OR #2 OR #3 OR #4 OR #5 
 
 
Database: Embase 
 
No Query 
#1 'vaccine management' OR 'vaccine stock management' 
#2 ('drug storage'/exp OR 'drug storage') AND ('vaccine'/exp OR 
vaccine OR 'vaccines'/exp OR vaccines) 
#3 'vaccine stockout' OR 'vaccines stockout' 
#4 ('vaccine'/exp OR vaccine OR 'vaccines'/exp OR vaccines) 
AND ('supply chain management'/exp OR 'supply chain 
management') 
#5 ('vaccine'/exp OR vaccine OR 'vaccines'/exp OR vaccines) 
AND ('supply and distribution'/exp OR 'supply and distribution') 
#6 #1 OR #2 OR #3 OR #5 
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Appendix 6: Interview guide used for the study on mobile reporting of vaccine stock-
levels in primary health care facilities in the Eastern Cape Province of South Africa: 
perceptions and experiences of health care workers 
 
 
1. Brief introduction of the participant 
2. Knowledge of the SVS and how the system works  
3. The effectiveness of the SVS in reducing occurrence of vaccine stock-outs   
4. Any challenges with using the SVS? 
5. If yes, what are the challenges? 
6. What is most challenging amongst them? 
7. Suggestions/recommendations for improvement 
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